2023 Speakers

Born to a poor immigrant family in New York City, Richard Carmona experienced homelessness, hunger, and health disparities during his youth. The experiences greatly sensitized him to the relationships among culture, health, education and economic status and ultimately shaped his future.

After dropping out of high school, Dr. Carmona enlisted in the U.S. Army in 1967 where he received a GED. By the time he left active duty, he was a Special Forces, combat-decorated Vietnam veteran. He then pursued a college degree and entered medical school at the University of California – San Francisco where he won the prestigious Gold Cane award as the top graduate.

Dr. Carmona became a surgeon with a sub-specialty in trauma, burns and critical care and was recruited to Tucson to establish the first trauma system in southern Arizona which he did successfully. Later, while working full time as a hospital and health system CEO, he earned a master’s degree in public health policy and administration at the University of Arizona.

Dr. Carmona served for over 35 years with the Pima County Sheriff’s Department in Tucson, including as deputy sheriff, detective, SWAT team leader and department surgeon. He is one of the most highly decorated police officers in Arizona, and his numerous awards include the National Top Cop Award, the National SWAT Officer of the Year, and the National Tactical EMS Award. Dr. Carmona is a nationally recognized SWAT expert and has published extensively on SWAT training and tactics, forensics, and tactical emergency medical support. Dr. Carmona has also served as a medical director of police and fire departments and is a fully qualified peace officer with expertise in special operations and emergency preparedness, including weapons of mass destruction.

In 2006 Vice Admiral Carmona successfully completed the statutory four-year term as Surgeon General and was named vice chairman of Canyon Ranch, CEO of the health division and president of the Canyon Ranch Institute. Dr. Carmona continues his Canyon Ranch leadership role as the Chief of Health Innovations. He also serves on several community and public corporate boards and works with private equity and venture capital firms to identify emerging science and technology to translate to market for economic and public benefit.

Dr. Michelle A. Williams stands as one of the most influential epidemiologists of her generation, combining rigorous scientific research with transformative academic leadership to advance global public health. Currently serving as Professor of Epidemiology and Population Health at Stanford University's School of Medicine, she brings a unique interdisciplinary perspective shaped by her background in biology, engineering, and epidemiology.

Dr. Williams' distinguished career includes her tenure as Dean of the Faculty at the Harvard T.H. Chan School of Public Health, where she provided strategic leadership for one of the world's premier public health institutions. Prior to this role, she served as Professor and Chair of the Department of Epidemiology at Harvard Chan School and led the Population Health and Health Disparities Research Programs at Harvard's Clinical and Translational Sciences Center. Her research portfolio, encompassing more than 550 scientific publications, focuses on reproductive, perinatal, pediatric, and molecular epidemiology with particular emphasis on addressing health disparities. This work has positioned her as a leading voice in understanding how social determinants and biological factors intersect to influence population health outcomes.

Dr. Williams' contributions to science and education have earned her election to the National Academy of Medicine in 2016, marking her as one of the most respected voices in her field. Her commitment to mentoring the next generation of public health leaders has been recognized through numerous prestigious awards, including the Presidential Award for Excellence in Science, Mathematics, and Engineering Mentoring from the White House in 2012, Harvard Chan School's Outstanding Mentor Award in 2015, and the American Public Health Association Abraham Lilienfeld Award for education in epidemiology in 2007.

Dr. Williams maintains active membership in several prestigious professional organizations, including the National Academy of Medicine, the Society for Epidemiologic Research, and the American Epidemiological Society. Her academic credentials include an undergraduate degree in biology and genetics from Princeton University, a master's degree in civil engineering from Tufts University, and both master's and doctoral degrees in epidemiology from Harvard T.H. Chan School of Public Health.

Gloria Caulfield holds multiple leadership roles, including Vice President of Strategic Alliances at Tavistock Development, President of the Lake Nona Institute, and Founder & Executive Director of the Lake Nona Impact Forum. She is responsible for developing corporate partnerships and collaborating with stakeholders in the Lake Nona community that advance medical innovation, technology, and leading-edge strategies for health & wellbeing in the built environment. Gloria is the chief architect and creative force for the Lake Nona Impact Forum, a revered global health innovation summit which is comprised of some of the world’s most pre-eminent thought leaders.

David Cameron served as Prime Minister of the United Kingdom of Great Britain and Northern Ireland from 2010 to 2016, leading Britain’s first Coalition Government in nearly 70 years and, at the 2015 General Election, forming the first majority Conservative Government in the UK for over two decades.

David Cameron came to power in 2010 at a moment of economic crisis and with an unprecedented fiscal challenge. Under his leadership, the UK’s economy was transformed. The deficit was reduced by over two-thirds; one million businesses set-up; a record number of jobs were created: 1,000 extra jobs for every day he was Prime Minister; and Britain became the fastest-growing major advanced economy in the world.

Internationally, David Cameron developed a foreign policy in the post-Iraq era that addressed the new challenges of the Arab Spring, as well as a more aggressive Russia, while ensuring that Britain played a full role in the global fight against ISIS. Under his leadership, Britain built a strong partnership with India and became China’s preferred partner in the West. Throughout, David championed Britain’s special relationship with the US, working closely with President Barack Obama.

Following hosting the successful London 2012 Olympic and Paralympic Games, David chaired the 2013 G8 Summit at Lough Erne in Northern Ireland, where he highlighted the global need for fair taxes, increased transparency and open trade.

He led the way internationally by passing the UK’s Same Sex Marriage Act, enabling those who love each other to get married whatever their sexuality; settled the UK’s voting practices for a generation through the first of three national referenda held while he was in No10; and offered two more decisive national votes: the first on Scotland’s place within the United Kingdom; the second on the United Kingdom’s place within the European Union.

David fought both campaigns the only way he knew how, which was to say directly and passionately what he thought and believed was right – head, heart and soul. In winning the 2014 Scottish referendum he ensured Scotland remained part of the United Kingdom. However, despite arguing that Britain was stronger, safer and better off inside the European Union, in June 2016, the British people voted to leave the EU. Following this defeat, David resigned as Prime Minister and Leader of the Conservative Party, leaving 10 Downing Street on 13 July 2016.

During his leadership of the party, he promoted social justice and social action; advanced the green agenda; set protecting the NHS as a top priority; and was proud to see a significant increase in the number of women and ethnic minority candidates standing for the Conservative Party and elected to Parliament.

Since leaving 10 Downing Street, David has continued focusing on issues he advanced while in office: supporting life chances for young people and building a bigger, stronger society; championing Britain’s cutting edge medical research; and promoting international development.

David is Chairman of Patrons at National Citizen Service (NCS), the UK’s flagship youth development programme that brings together teenagers from all parts of the country for a part-residential experience.

He is also President of Alzheimer’s Research UK, Britain’s leading medical research charity with special focus on funding bio-medical research into the cause, prevention and cure of dementia.

And continuing the instrumental role he took while Prime Minister advocating UN Sustainable Development Goal 16, he has been working with the London School of Economics and Blavatnik School of Government at Oxford University by chairing the LSE-Oxford Commission on State Fragility, Growth and Development, under the auspices of the International Growth Centre. He also sits on the Global Board of Advisors at the Council on Foreign Relations and is a Board member of the ONE Campaign.

Further to these roles, David is advising and working with a number of international businesses, concentrating on technology, finance and medical innovation sectors.

Karmel Allison has spent more than 15 years working in ML and AI. She is currently a Technical Advisor in the Office of the CTO at Microsoft, helping to usher in an AI-enabled future across Microsoft and OpenAI, and in previous lives she led the TensorFlow Keras and Core APIs team at Google and received a PhD in Bioinformatics from the University of California, San Diego.

Jennifer is Senior Vice President, 5G Acceleration, Verizon Business. She is an experienced sales leader and general manager with an aptitude for creating diverse teams and fostering global perspectives.

She is responsible for catalyzing the adoption and commercialization of 5G across industries and enabling rapidly scalable deployment of 5G solutions to enterprises in the U.S. and around the world.

With keen knowledge of customers’ operations and unique needs, Jennifer and the 5G Acceleration Team use Verizon’s strength in building reliable networks and intelligent connectivity solutions to help businesses realize new capabilities, solve operational problems, and get to revenue faster.

Prior to joining Verizon Jennifer served as the President, BT in the Americas and MD, Technology, Life Sciences and Business Services where she led BT’s entire Americas team in the United States, Canada and Latin America and ran a global sales vertical focused on Technology, Life Sciences and Business Services customers. As the leader of one of three global vertical sales units, Artley built and grew relationships with BT’s top 800 customers in this ~£1.2B sales channel. She brought together the knowledge, resources, and skills of her global team to address customers’ complex digital transformations with insight, consistency, and agility.

Jennifer earned her Bachelor of Arts at Hobart and William Smith Colleges, her Master of Business Administration from University of Pennsylvania - Wharton School of Business, and her Master of Arts from The Lauder Institute at the University of Pennsylvania. She is fluent in Spanish and proficient in Russian. Jennifer was also a founding member and later an Advisory Board member of Minds Matter of Denver, a non-profit focused on mentoring and supporting unique educational opportunities for high achieving high school students from low income neighborhoods. Jennifer currently resides in Denver, Colorado with her husband and two daughters.

Founder of The Overtone Group, and former Chairman and CEO of Cardinal Health, a Fortune 20, multinational healthcare services company. Director of multiple corporate and nonprofit boards, visiting professor at NYU and Columbia University, musician, advisor on public policy issues, and mentor to senior executives and next generation of leaders. Recipient of multiple honors for a life dedicated to statesmanship and community service.

Iconic Grammy and Emmy Award-winning and Oscar-nominated artist, actress, producer, and entrepreneur Mary J. Blige is a figure of inspiration, transformation, and empowerment. With a track record of eight multi-platinum albums, nine Grammy Awards (37 nominations), an Emmy award, two Academy Award nominations, two Golden Globe nominations, and a SAG nomination, Blige has cemented herself as a global superstar.

Influenced at an early age by the music of Aretha Franklin, Chaka Khan and Gladys Knight, Blige brought her own gritty, urban-rooted style—fusing hip-hop, soul, and honest, frank lyrics—to the forefront on her 1992 debut album What’s the 411? Blige continued to redefine R&B and began forging a unique niche for herself on her second album, 1994’s My Life.

Each subsequent album she released reads like a chapter from an autobiography leading to February 2022, when Blige released her 15th studio album Good Morning Gorgeous, which has since earned her six 2023 Grammy nominations including Album and Record of the Year. The album release led into a historic performance at the Pepsi Super Bowl LVI Halftime Show at SoFi Stadium in Inglewood, CA alongside Dr. Dre, Eminem, Snoop Dogg, and Kendrick Lamar. Her performance earned her a 2022 Emmy Award for Outstanding Variety Special (Live).

Following the success of this performance, Blige and Pepsi announced the inaugural “Strength of a Woman Festival and Summit” in partnership with Live Nation Urban. The festival quickly sold out and will be back for its second year this May in Atlanta, GA.

On the acting side, Blige starred as Florence Jackson in the 2017 Netflix breakout film Mudbound, to which she received critical acclaim including two Academy Award nominations for Best Support Actress and Best Original Song. Among many other credits, Blige is currently starring in STARZ’s POWER BOOK II: GHOST, which will premiere its third season in March 2023.

On the producing side, Blige launched her production company, Blue Butterfly, and signed a first-look TV deal with Lionsgate. Blige also signed a first-look non-scripted deal and a second-look scripted deal with BET. In 2021, Blige worked with Oscar-winning filmmaker Vanessa Roth and Amazon on her documentary Mary J. Blige's My Life celebrating the 25th anniversary of her famed album My Life, of which she was the focus and EP.

David Blumenthal is President Emeritus of the Commonwealth Fund and was previously Chief Health Information and Innovation Officer at Partners Health System, and Samuel O. Thier Professor of Medicine and Professor of Health Care Policy at Massachusetts General Hospital/ Harvard Medical School. He was National Coordinator for Health Information Technology under President Barack Obama from 2009-2011.

Barbara Bouza is president of Walt Disney Imagineering, where she heads the global creative, design and development teams behind Disney’s theme parks, attractions, resort hotels, cruise ships, and retail, dining and entertainment centers. She also leads a multidisciplinary team tasked with exploring, developing and bringing to market groundbreaking ideas that enhance and expand Disney’s portfolio of experiences around the world.

Barbara previously served as co-managing director, principal, of Gensler Los Angeles. A fellow of the American Institute of Architects (AIA), she was the 2019 AIA Los Angeles president, and also served on the board of the Southern California chapter of the International Interior Design Association.

Barbara is on the board of directors of Imagine LA, a leading not-for-profit dedicated to mobilizing the community to end the cycle of family homelessness and poverty, and is a member of the National Organization of Minority Architects and the Women Presidents’ Organization. Additionally, she works with nonprofit organizations such as Girls Inc. and Dress for Success.

Barbara holds a Bachelor of Architecture degree from California State Polytechnic University, Pomona, and studied in the Graduate Diploma Program at the Architectural Association in London.

John Hope Bryant is an American entrepreneur, thought leader and philanthropic leader. He is referred to as the Conscience of Capitalism by the CEOs of Delta Air Lines, Walmart, and
countless others. Mr. Bryant is the Founder, Chairman, and Chief Executive Officer of Operation
HOPE, Inc. the largest non-profit provider of financial literacy and economic empowerment services in the United States. Bryant is also Chairman and Chief Executive Officer of John Hope Bryant Holdings, Bryant Group Ventures and Executive Chairman of The Promise Homes Company, the largest for-profit minority-controlled owner of institutional-quality, single-family residential rental homes in the U.S.

Bryant has been recognized as an influential leader by many. He has received hundreds of awards and citations for his work, including Oprah Winfrey’s Use Your Life Award, and the John Sherman Award for Excellence in Financial Education from the U.S. Department of Treasury. Bryant has also received the 100 Black Men of America “Chairman’s Award for Economic Empowerment,” he was listed by The Atlanta Business Chronicle’s “2022 Power 100”, named #2 among 100 inspirational leaders on the “Yahoo Finance Empower Role Model list 2022," Georgia Trend’s “100 Most Influential Georgians” in 2022, 2023 and 2024, Atlanta Business Chronicle’s “Most Admired CEOs of 2018,” Atlanta Business Chronicle’s “The Power 100: Most Influential Atlantans in 2020,” American Banker magazine's 2016 “Innovator of the Year,” and one of Time magazine’s “50 Leaders for the Future” in 1994. Bryant received an honorable mention in Inc. Magazine’s “The World’s 10 Top CEOs” an article that spotlights global servant leaders as the visionaries behind some of the most successful organizations.

Five former U.S. presidents have recognized Bryant’s work, and he has served as an advisor to three sitting U.S. presidents from both political parties. In 2008, Bryant inspired President George W. Bush to make financial literacy the official policy of the U.S. federal government.

Bryant is the author of Up from Nothing: The Untold Story of How We (All) Succeed; The Memo: Five Rules for Your Economic Liberation, How the Poor Can Save Capitalism: Rebuilding the Path to the Middle Class, and LOVE LEADERSHIP: The New Way to Lead in a Fear-Based World (Jossey-Bass, 2009).

Sebastien Bubeck is a Senior Principal Research Manager in the Machine Learning Foundations group at Microsoft Research (MSR). He joined the Theory Group at MSR in 2014, after three years as an assistant professor at Princeton University. His works on convex optimization, online algorithms and adversarial robustness in machine learning received several best paper awards (NeurIPS 2021 best paper, NeurIPS 2018 best paper, ALT 2018 best student paper in joint work with MSR interns, COLT 2016 best paper, and COLT 2009 best student paper). Recently he has been focused on exploring a physics-like theory of neural networks learning.

Lauren Bush Lauren is the Founder and CEO of FEED, an impact-driven brand founded upon the belief that food is a universal human right. Every FEED product sold provides school meals to children through direct donations to our on-the-ground partners. Since 2007, FEED has helped provide over 126 million school meals around the world and here in the U.S.

For her work with FEED, Lauren has received multiple awards, including Fortune Magazine’s Most Powerful Women Entrepreneurs in 2009 and Inc. Magazine’s 30 Under 30 in 2010. In 2015, she was named a World Economic Forum Young Global Leader. Lauren resides in New York City where she also serves on the Board of Directors for the Food Bank for NYC. Outside of work, Lauren’s most important role is as Mama to three boys – James, Max, and Rocky.

Dr Mobasher Butt has 20 years of international experience as a senior physician executive and clinical practitioner. He was previously the Global Medical Vice-President at Babylon, a leading healthcare organisation. Prior to this Mobasher held roles at the World Health Organisation, British Medical Journal, NHS London and the UK Department of Health. Mobasher has disrupted healthcare globally by building and deploying cutting edge AI solutions and digital health services in 17 countries. He was pivotal in developing Babylon’s business from a pre-series start-up to IPO valued at $4.2 billion dollars. Mobasher has collaborated with governments, regulators and commercial partners worldwide.

As a primary care physician, Mobasher has focused his career on improving healthcare through innovation. As a partner in the NHS GP at Hand service, he established a ground-breaking digital primary care service, which was both the first service of its kind in the UK NHS’ 70 year history and one of the fastest growing NHS services ever. Mobasher was named the most influential GP in the UK in 2018 and has extensive clinical experience in the UK and overseas, in both developed and developing country settings. He holds an MPH from the London School of Hygiene and Tropical Medicine, an MD from University College London, and a Healthcare Management BSc (Hons) from Imperial College London.

Robin is the Ralph Metzner Distinguished Professor in Neurology and Psychiatry and Director Neuroscape’s Psychedelics Division at the University of California, San Francisco. He moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology. Robin has designed human brain imaging studies with LSD, psilocybin, MDMA and DMT, and clinical trials of psilocybin therapy for severe mental illnesses.

Juju Chang is an Emmy® Award-winning co-anchor of ABC News’ “Nightline.” She also reports regularly for “Good Morning America” and “20/20.”

Chang has been recognized for her in-depth personal narratives set against the backdrop of pressing national and international news. From mass shootings to the Opioid Epidemic, Chang is a veteran journalist with a wide-ranging body of work. Chang reported on the recent rise of hate crimes toward the Asian American and Pacific Islander (AAPI) community as anchor of the ABC News Live special “Stop The Hate: The Rise In Violence Against Asian Americans” and the “20/20” special “Murder In Atlanta” following the Atlanta mass shooting.

Chang’s decades-long career has been recognized with numerous awards, including multiple Emmy’s, Gracie’s, a DuPont, a Murrow and Peabody awards. In 2017, she was honored with the Lifetime Achievement Award at the Front Page Awards.

Born in Seoul, South Korea, and raised in Northern California, Chang graduated with honors from Stanford University. A former news anchor for “Good Morning America,” Chang joined ABC News just after college. Chang is a co-founder of the Korean American Community Foundation and a recipient of the Justice in Action Award from the Asian American Legal Defense and Education Fund. She is a pandemic gardener, devoted wife and mother to 3 sons who identify as “50% Korean and 100% Jewish.”

DEEPAK CHOPRA MD, FACP, FRCP, is a Consciousness Explorer and a world-renowned pioneer in integrative medicine and personal transformation. Chopra is co-founder of DeepakChopra.ai, his AI twin and well-being advisor. He also co-founded Cyberhuman, a transformative suite of personalized health and well-being solutions. Chopra is a Clinical Professor of Family Medicine and Public Health at the University of California, San Diego, and serves as a senior scientist with Gallup Organization. He is also an Honorary Fellow in Medicine at the Royal College of Physicians and Surgeons of Glasgow. He is the author of over 95 books, translated into over forty-three languages, including numerous New York Times bestsellers.

For the last thirty years, Chopra has been at the forefront of the meditation revolution. His mission is to create a more balanced, peaceful, joyful and healthier world. Through his teachings, he guides individuals to embrace their inherent strength, wisdom, and potential for personal and societal transformation.

In his latest book, *Digital Dharma* (Harmony/Rodale, 09/17/24), Chopra navigates the balance between technology and expanded awareness, explaining that while AI cannot duplicate human intelligence, it can vastly enhance personal and spiritual growth. TIME magazine has described Dr. Chopra as “one of their top 100 most influential people”.

Chaplain Clementina Chéry is the Founder, President & CEO of the Louis D. Brown Peace Institute in Boston, Massachusetts. The Peace Institute is a center of healing, teaching, and learning for families and communities impacted by murder, trauma, grief, and loss. Chaplain Chéry and her family founded the Peace Institute in 1994 after her 15-year-young son Louis D. Brown was murdered in the crossfire of a shootout.

Chaplain Chéry has developed the best practices in the field of homicide response. Her professional goal is to transform society’s response to homicide so that all families are treated with dignity and compassion, regardless of the circumstances. Her spiritual goal is to become a Minister of God’s Peace that is rooted in love, unity, faith, hope, courage, justice, and forgiveness.

Chaplain Chéry has extensive experience training public health professionals, law enforcement officials, and faith leaders to better serve families impacted by murder. She has trained members of the Miami Police Department Homicide Unit to respond equitably and effectively to homicide, and convened the first-ever Homicide Response Briefing in Massachusetts for over 100 law enforcement officials from across the state. She has also led trainings for the Massachusetts Office of Victim Assistance.
She has also trained doctors, social workers, psychologists, street workers, and other providers at city and state agencies, hospitals, and community-based organizations.

Her groundbreaking publications for families of murder victims and the providers who serve them include “Always in My Heart: A Workbook for Grieving Children” (2011) and the Survivors Burial and Resource Guide (2013). The Survivors Burial and Resource Guide offers step-by-step guidance to families of murder victims. Chaplain Chéry is also coauthor of an article entitled “Homicide Survivors: Research and Practice Implications,” which was published in the American Journal of Preventive Medicine in 2005.

In 2023, she launched The Peace Principle, a podcast where she leads conversations on ways to heal our wounded hearts.

Chaplain Chéry received an honorary Doctorate of Ministry from the College of the Holy Cross in Worcester, Massachusetts and was ordained as a senior chaplain with the International Fellowship of Chaplain, Inc. in 2012.

Her greatest accomplishments are being the mother of Louis, Alexandra and Allen, and the grandmother of Alexander, Adriel, and Amani.

As vice chair of the Clinton Foundation, Chelsea Clinton works alongside the Foundation’s leadership and partners to improve lives and inspire emerging leaders across the United States and around the world. This includes the Foundation’s early child initiative Too Small to Fail, which supports families with the resources they need to promote early brain and language development; and the Clinton Global Initiative University (CGI U), a global program that empowers student leaders to turn their ideas into action. A longtime public health advocate, Chelsea also serves as vice chair of the Clinton Health Access Initiative and uses her platform to increase awareness around issues such as vaccine hesitancy, childhood obesity, and health equity.

In addition to her Foundation work, Chelsea teaches at Columbia University’s Mailman School of Public Health and has written several books for young readers, including the #1?New York Times bestseller?She Persisted: 13 American Women Who Changed the World?as well as?She Persisted Around the World,?She Persisted in Sports,?She Persisted in Science, Start Now! You Can Make a Difference;?Don’t Let Them Disappear; It’s Your World: Get Informed, Get Inspired & Get Going; and Welcome to the Big Kids Club.?She is also the co-author of?The Book of Gutsy Women?and?Grandma’s Gardens?with Secretary Hillary Rodham Clinton and of?Governing Global Health: Who Runs the World and Why??with Devi Sridhar. Chelsea’s podcast, In Fact with Chelsea Clinton, premiered in 2021 and is the co-founder of HiddenLight Productions.

Chelsea holds a Bachelor of Arts from Stanford, a Master of Public Health from Columbia's Mailman School of Public Health, and both a Master of Philosophy and a Doctorate in international relations from Oxford University. She lives with her husband Marc, their children Charlotte, Aidan and Jasper, and dog Soren in New York City.

Robin Cogan, MEd, RN, NCSN, FNASN, FAAN is a New Jersey school nurse in the Camden City School District. Robin is the Director from NJ for the National Association of School Nurses. She is on faculty at Rutgers University-Camden School of Nursing. Robin writes a popular blog called The Relentless School Nurse. Her extensive career in school nursing was included as a case study in the National Academies of Medicine Future of Nursing 2030 report. Follow Robin on Twitter @RobinCogan

Josh Cohen co-founded Amylyx Pharmaceuticals in 2013 and has served since that time as its Co-CEO and Co-Founder. Josh co-invented AMX0035 and has overseen the growth of Amylyx from its start as a concept dreamed up in a dorm room to its status now as a pre-commercial stage pharmaceutical company. Together with Justin, Josh has raised nearly $250M in financing to support the development of new therapies for ALS and other neurodegenerative diseases. Josh received his Bachelor of Science in Biomedical Engineering from Brown University.

Francis S. Collins, M.D., Ph.D., currently serves as the Special Advisor to President Biden for Special Projects. In this role, he is leading a bold program to help eliminate Hepatitis C in the United States. Dr. Collins also maintains his longstanding position as a Senior Investigator in the intramural program of the National Human Genome Research Institute, pursuing genomics research on type 2 diabetes and a rare disorder of premature aging called progeria.

Dr. Collins previously served as the 16th Director of the National Institutes of Health (NIH), appointed by President Barack Obama and confirmed by the Senate in 2009. In 2017, President Donald Trump asked Dr. Collins to continue to serve as the NIH Director. President Joe Biden did the same in 2021. For those 12 years, serving an unprecedented three administrations, Dr. Collins oversaw the work of the largest supporter of biomedical research in the world, spanning the spectrum from basic to clinical research. Dr. Collins stepped down as Director on December 19, 2021.

Dr. Collins is a physician-geneticist noted for his landmark discoveries of disease genes and his previous leadership of the international Human Genome Project, which culminated in April 2003 with the completion of a finished sequence of the human DNA instruction book. He served as director of the National Human Genome Research Institute at NIH from 1993-2008.

Dr. Collins is an elected member of both the National Academy of Medicine and the National Academy of Sciences, was awarded the Presidential Medal of Freedom in November 2007, and received the National Medal of Science in 2009. In 2020, he was elected as a Foreign Member of the Royal Society (UK) and was also named the 50th winner of the Templeton Prize, which celebrates scientific and spiritual curiosity.

Dr. Kizzmekia S. Corbett is an assistant professor of immunology and infectious diseases at Harvard’s T.H. Chan School of Public Health, Shutzer Assistant Professor at Harvard’s Radcliff Institute of Advanced Study, and Associate Member of the Phillip T. and Susan M. Ragon Institute. Dr. Corbett’s laboratory studies host immune responses to coronaviruses and other emerging and re-emerging viruses to propel novel vaccine and antibody therapy development. In 2008, she received a BS in Biological Sciences, with a secondary major in Sociology, from the University of Maryland – Baltimore County, where she was a Meyerhoff Scholar and NIH undergraduate scholar. She then obtained her PhD in Microbiology and Immunology in 2014 from the University of North Carolina at Chapel Hill holding multiple honors, including a director’s scholarship. Prior to Harvard, she was a research fellow and scientific lead at the National Institute of Allergy and Infectious Diseases Vaccine Research Center. A leading COVID-19 vaccine, mRNA-1273, was co-designed by Dr. Corbett’s NIH team from viral sequence and rapidly deployed to industry partner, Moderna, Inc., for Phase 1 clinical trial, which unprecedently began only 66 days from viral sequence release. mRNA-1273 is a now used around the world to prevent COVID-19 disease. Alongside mRNA-1273, Dr. Corbett boasts a patent portfolio which also includes universal coronavirus and influenza vaccine concepts and novel therapeutic antibodies. In all, she has over 15 years of experience studying dengue virus, respiratory syncytial virus, influenza virus, and coronaviruses, garnering several prestigious awards and recognitions, such as being named a Time Magazine “Hero of the Year” in 2021. Combining her research goals with her knack for mentorship, Dr. Corbett invests much of her time in underserved communities as an advocator of STEM education and vaccine awareness.

Katie Couric (@katiecouric) is an award-winning journalist and #1 New York Times best-selling author of her memoir, Going There, which was published in October 2021. She is also a co-founder of Stand Up To Cancer (SU2C) which has raised more than $700 million for cancer research.

Couric was the first woman to solo anchor a network evening newscast, serving as anchor and managing editor of the CBS Evening News from 2006 to 2011 following 15-years as co-anchor of NBC’s Today show.

In 2017, she founded Katie Couric Media (KCM), which has developed a number of media projects, including a daily newsletter, “Wake-Up Call”, a podcast, “Next Question”, digital video series and several documentaries. You can find it all at katiecouric.com.

John F. Crowley is the President and CEO of the Biotechnology Innovation Organization (BIO), the world’s largest biotechnology advocacy organization. Crowley, a longtime BIO board member, was most recently the Founder and Executive Chairman of Amicus Therapeutics, a global biotechnology company focusing on developing treatments for rare genetic diseases. He served as Chief Executive Officer of Amicus from 2005 to 2022.

John’s decades of biotech experience and deep passion for the field have made him a strong supporter of policies that empower innovation, enable entrepreneurship, and put people and patients first. His involvement with biotechnology stems from the 1998 diagnosis of two of his children with Pompe disease—a severe and often fatal neuromuscular disorder.

John and his family have been profiled numerous times by The Wall Street Journal. The 2010 major motion picture, Extraordinary Measures, starring Brendan Fraser, Harrison Ford, and Keri Russell, is inspired by the Crowley family journey. John also served as a commissioned officer in the U.S. Navy Reserve from 2005-2016. He is a veteran of the global war on terrorism, and his assignments included service with the Joint Special Operations Command (JSOC), the Naval Special Warfare Development Group (NSWDG), and the Central Intelligence Agency (CIA).

John attended the U.S. Naval Academy and went on to earn a B.S. in Foreign Service from Georgetown University, a J.D. from the University of Notre Dame Law School, and an M.B.A. from the Harvard Business School.

Academy Award winner Geena Davis is one of Hollywood’s most respected actors, appearing in several roles that became cultural landmarks.

Davis received her first Academy Award, for Best Supporting Actress, for her role as the offbeat dog trainer Muriel Pritchett in Lawrence Kasdan’s The Accidental Tourist. She was again nominated for an Academy Award and Golden Globe for her performance in Ridley Scott’s Thelma & Louise, in which she co-starred with Susan Sarandon.

In 2019 Davis was honored with a second Oscar, this time the Academy’s Jean Hersholt Humanitarian Award, in recognition of the work Davis has done over the decades to achieve gender parity onscreen in film and television.

Earning the 2006 Golden Globe Award for Best Performance by an Actress in a Television Series – Drama, Davis broke ground in her portrayal of the first female President of the United States in ABC’s hit show Commander in Chief.

Davis made her feature film debut starring opposite Dustin Hoffman in Tootsie. She went on to star in such films as The Fly, Beetlejuice, The Long Kiss Goodnight, Stuart Little, and A League of Their Own.

Few have achieved such remarkable success in as many different fields as Davis has: she is not only an Oscar and Golden Globe-winning actor, but a world-class athlete (at one time the nation’s 13th-ranked archer), a member of the genius society Mensa, and is now recognized for her tireless advocacy of women and girls nearly as much as for her acting accomplishments. She is the Founder and Chair of the non-profit Geena Davis Institute on Gender in Media, which engages film and television creators to dramatically increase the percentage of female characters — and reduce gender stereotyping — in media made for children 11 and under.

Davis also serves as the Chair of the Bentonville Film Festival Foundation a year-long initiative focused on promoting underrepresented voices of diverse storytellers in entertainment and media through research, education, and supporting the production and distribution of inclusive content.

Davis is an Executive Producer on the Gracie Award winning feature film This Changes Everything and Emmy nominated, People’s Choice and Gracie Award winning television show Mission Unstoppable on CBS.

Davis holds honorary degrees from Boston University, Bates College, and New England College

Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary’s Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and puppy, with three empty rooms from his children whom have all graduated college and begun their life journeys.

Victor J. Dzau is the President of the US National Academy of Medicine (NAM). In addition, he serves as Vice Chair of the US National Research Council. He is Chancellor Emeritus and James B. Duke Professor of Medicine at Duke University and the past President and CEO of the Duke University Health System.

Todd is a KPMG advisory principal focused on the healthcare industry. He also serves as the MidSouth Advisory Hub Leader, responsible for people and partner connectivity and supporting community and philanthropic initiatives. With over 20 years’ experience working with payors and providers across the country and globally, Todd has particular strengths in Health Equity, EHR design and implementation, intelligent automation, large scale IT system transformation, population health management, Medicaid IT transformation and enterprise transformation. Todd has authored numerous thought leadership papers on health equity, and leads KPMG’s support to large healthcare providers and medical schools as they deploy a data-led approach to identifying and addressing health inequity in their communities and nationally.

Todd is an active member in the Atlanta community, serving as a board member for CHRIS 180 which assists homeless youth in Atlanta, a Leadership Atlanta Alumnus (2018), a member of 100 Black Men of Atlanta, a board member of the Atlanta Opera and a member of the Grady Hospital Ambassador Force which focuses on serving and ensuring underrepresented populations receive the best medical care possible.

Mick Farrell is CEO of ResMed, the global leader in digital health for respiratory medicine and residential medicine, with 19 million 100%-cloud-connectable medical devices in 140 countries. Mick serves on the board of directors for ResMed, Zimmer Biomet, and AdvaMed. He was educated at MIT and volunteers for non-profits, including Father Joe’s Village for homeless residents in San Diego, California.

As Cerner’s president and CEO, David Feinberg, M.D., focuses on delivering tools and technology that help caregivers optimize the health of their patients and communities. As a pediatric psychiatrist, David built his early career around helping children and families.

He served as president and CEO of both UCLA Health and Geisinger Health prior to assuming leadership of Google Health in early 2019. His work at UCLA provided David with a clear view of how patient satisfaction translates to clinical success. His focus on the patient experience increased UCLA’s patient satisfaction scores from the 28th to the 99th percentile.

At Geisinger, David led a complex turnaround that made Geisinger one of the nation’s most innovative healthcare providers, including a first-of-its kind clinical program that made DNA sequencing a routine part of patient care. David also guided Geisinger’s transition to value-based care using Cerner’s population health platform, HealtheIntent, integrated with a non-Cerner EMR.

At Google, David leveraged Google’s technology, talent and search capabilities to tackle healthcare’s most important challenges. Under David’s leadership, Google was at the forefront of using Artificial Intelligence and mobile platforms to improve healthcare and – in partnership with Ascension Health – produced Care Studio, a tool that organizes patient records for healthcare clinicians at the point of care.

David began his career at UCLA, researching and publishing in the areas of addiction and attention deficit hyperactivity disorder. He took on additional leadership responsibilities, including becoming the Medical Director of the Resnick Neuropsychiatric Hospital. By implementing rigorous service metrics and patient satisfaction measures and completing a financial turnaround, UCLA’s neuropsychiatric hospital is now considered the premier psychiatric hospital in the western United States.

David earned his M.D. from Chicago Medical School in 1989, finishing at the top of his class and is a member of the Alpha Omega Alpha Medical Honor Society. He also holds an economics degree from the University of California-Berkeley and an MBA from Pepperdine University.

Pat Geraghty is President and CEO of GuideWell, a $30 billion not-for-profit mutual insurance holding company headquartered in Jacksonville, Fla., serving 38.5 million people across 50 states, Puerto Rico and the U.S. Virgin Islands.

GuideWell comprises Florida’s Blue Cross Blue Shield plan, Florida Blue, the leading health insurer in Florida; Triple-S Management, Puerto Rico’s Blue Cross Blue Shield plan and a leading health care services company on the island; GuideWell Health, a portfolio of clinical delivery organizations; PopHealthCare and its value-based national medical group Emcara Health; GuideWell Source, which provides administrative services to federal health care programs; and WebTPA, a market leading administrator of self-funded employer health plans. The company holds majority or significant interests in a range of health solutions companies including Lucet, a behavioral health care company that provides technology-enabled support to payers, providers, and health plan members. Through a joint venture with Keralty, a multinational health business group with more than 40 years of global experience, GuideWell is expanding care delivery across Florida through more than 40 Sanitas direct care delivery locations.

A dynamic speaker, Geraghty is considered an expert voice on a range of health care topics including U.S. health care reform, next-generation payment strategies, health care innovation and the benefits of wellness and prevention programming. He is frequently sought for his insights on important health care policy matters in Washington, D.C. and Tallahassee, Fla.

Geraghty is a member and past chair of the Florida Council of 100 and a member of the board of the Blue Cross Blue Shield Association, including chair of its Health Policy & Advocacy Committee; National Institute of Health Care Management; America’s Health Insurance Plans; and Tampa Electric Co.

Geraghty holds a Bachelor of Arts degree from Colgate University and a Doctor of Humane Letters, honoris causa, from Florida Southern College. He also has completed executive education programs at Harvard University School of Public Health and the Wharton School at the University of Pennsylvania.

Carey Goldberg is co-author (with Peter Lee and Zak Kohane) of the upcoming book “The AI Revolution in Medicine,” to be published by Pearson in April. Carey is a longtime medical and science journalist who has covered a broad gamut of health-related topics, from costs of care to life science research. She has been the Boston bureau chief of Bloomberg News and of The New York Times, and has reported on health and science for The Boston Globe and WBUR/NPR. In her earlier career, she was a staff Moscow correspondent for The Los Angeles Times, covering the collapse of the Soviet Union and the stormy period that followed. Carey has won multiple journalism prizes, including an Edward R. Murrow award for media innovation, and spent a year as a Knight Science Journalism Fellow at MIT. She co-authored a 2010 memoir from Little, Brown, “Three Wishes: A True Story of Good Friends, Crushing Heartbreak and Astonishing Luck on Our Way To Love and Motherhood.”

Lori F. Gooding, PhD, MT-BC, is Associate Professor of Music Therapy at Florida State University and President of the American Music Therapy Association. Her research interests include music therapy in biopsychosocial and family-centered care, and she has published and presented nationally and internationally. Dr. Gooding recently completed a Fulbright grant to Malaysia where she worked with colleagues from the Universiti Putra Malaysia to build the foundation for the first music therapy degree program in the country.

Robert Green, MD, MPH is a board-certified medical geneticist and Professor of Medicine at Harvard Medical School who directs the Genomes2People Research Program at Mass General Brigham, Ariadne Labs and the Broad Institute.

Dr. Green’s empirical research and policy development is accelerating the implementation of genomic and precision medicine. His work has established the safety and feasibility of disclosing various forms of genetic risk information, assessed the impact of whole genome sequencing in primary care, created the concept of aggregate penetrance of genomic variants in a prospective population cohort and provided early data on the clinical utility and cost-effectiveness of genomic sequencing in healthy adults (the MedSeq Project), and in active duty military personnel (the MilSeq Project). Most recently Dr. Green is leading the first empirical trial of comprehensive sequencing in healthy newborn infants, the NIH-funded BabySeq Project.

Dr. Green established the world’s first academically-affiliated, family-oriented Preventive Genomics Clinic in Boston and led policy development for returning genomic information to research participants within the Global Alliance for Genomics and Health, the Verily-Google Baseline Project and All of Us Research Program. In 2017, he co-founded the nationwide telegenetics company Genome Medical.

Dr. Sanjay Gupta is the award-winning chief medical correspondent for CNN, host of the CNN podcast Chasing Life, and a practicing neurosurgeon.

Since 2001, Dr. Gupta has covered some of the most important health stories around the world. On March 9, 2020, Dr. Gupta penned an op-ed announcing the network would refer to the novel coronavirus outbreak as a “pandemic,” ahead of the WHO and the CDC. Throughout 2020 into 2021, Dr. Gupta reaffirmed his role as a trusted guide to viewers worldwide navigating between facts and fiction surrounding Covid-19 and the pandemic.

Dr. Gupta is an associate professor of neurosurgery at Emory University Hospital and associate chief of neurosurgery at Grady Memorial Hospital in Atlanta. He serves as a diplomat of the American Board of Neurosurgery. In 2019, Dr. Gupta was elected to the National Academy of Medicine, considered one of the highest honors in the medical field. He is a best-selling author, including It Doesn’t Have to Hurt: Your Smart Guide to a Pain-Free Life, published in 2025.

Dr. Sanjay Gupta received his undergraduate degree from the University of Michigan and a Doctorate of Medicine degree from the University of Michigan Medical School.

Seth Hain, Senior Vice President of R&D at Epic, focuses on advancing the use of analytics and machine learning in healthcare to improve care and efficiency. During his 17 years at Epic, Seth has worked on enhancing the core analytics and AI technologies in Epic’s platforms and their application to the clinical domain. While at Epic, he has also headed the system and performance team, with a focus on database performance and architecture. A native of Seward, Nebraska, he received a BS in Mathematics from the University of Nebraska and an MS in Mathematics from the University of Wisconsin. Seth currently lives in Madison, Wisconsin with his wife and two children.

Patrice A. Harris, MD, MA is the CEO and Co-Founder of eMed, a digital healthcare company. She is a board certified psychiatrist from Atlanta and has diverse experience as a private practicing physician, county public health director and patient advocate and expertise in policy, legislative and government affairs. Dr. Harris was the 174th President of the American Medical Association and the first African American woman elected to that position. Dr. Harris is a visiting professor of psychiatry at the Columbia University Vagelos College of Physicians and Surgeons and serves as Chief Health and Medical Editor of Everydayhealth.com.

Beyond the AMA she has held positions of leadership with the American Psychiatric Association, the Georgia Psychiatric Physicians Association, the Medical Association of Georgia, and The Big Cities Health Coalition, where she chaired this forum composed of leaders from America’s largest metropolitan health departments. She is a member of the Steering Committee of the Atlanta Regional Collaborative for Health Improvement (ARCHI) and the Board of the Georgia Aids Coalition. She also serves on the Board of Quartet Health.

Dr. Harris spent her formative years at West Virginia University, earning a BA in psychology, an MA in counseling psychology and, ultimately, a medical degree (MD). She completed her psychiatry residency and fellowships in child and adolescent psychiatry and forensic psychiatry at the Emory University School of Medicine

Dr. Harris is a highly sought after speaker at national and international conferences and has given invited lectures and presentations on COVID-19, children’s mental health, childhood trauma, integration of mental health into overall health services, health equity, health policy and the intersection of athletics and health. She has been a guest expert on multiple national radio and television networks including CNN, MSNBC, Fox and NPR. Dr. Harris has received numerous awards in recognition of her service and leadership.

Dr. Harris is fellow of the American Psychiatric Association and is adjunct assistant professor in the Emory Department of Psychiatry and Behavioral Sciences, and an adjunct clinical assistant professor in psychiatry and behavioral sciences at the Morehouse School of Medicine.

Dr. Susan Harvey is currently the Vice President of Global Medical Affairs at Hologic, a medical technology innovator focused primarily on women’s health. She joined the organization in April 2019, and her current goal is to help elevate women’s health and wellbeing worldwide. That includes her leadership role with the Hologic Global Women’s Health Index, the most comprehensive survey – conducted in partnership with Gallup – about women’s health. The Index provides a science-backed, data-driven roadmap for countries to improve the wellbeing of women and girls.

Susan was the Director of Breast Imaging for Johns Hopkins Medicine for over 7 years, overseeing the organization’s growth in the areas of clinical service, teaching, and research. She has worked in underserved and resource-scarce regions around the world to identify the most appropriate detection, diagnosis and treatment opportunities in these resource constrained areas.

Susan attended medical school at the University of Vermont (UVM) and completed her residency in diagnostic radiology at Yale New Haven Hospital before completing a fellowship in Oncoradiology with a focus in breast cancer care at the Brigham and Women’s Hospital and The Dana Farber Institute in Boston. She joined the faculty at Brigham and Women’s Hospital for four years, then returned to UVM where she continued practicing until 2005 when she joined Johns Hopkins Medicine as a full-time breast imager. While at Hopkins, Susan held leadership positions in the department of radiology including being the Director of breast imaging. She received many student mentoring awards in the School of Medicine, Bloomberg School of Public Health and in Biomedical Engineering as well as being elected as a member of the Miller Coulson Academy of Clinical of Excellence. Currently Susan is on the Board of Directors for Johns Hopkins Biomedical Engineering.

Dr. Mark Hyman is a global leader in Functional Medicine. He is the founder of The UltraWellness Center, Senior Advisor for the Cleveland Clinic Center for Functional Medicine, a 14x NY Times best-selling author. He is the host of one of the leading health podcasts, The Doctor’s Farmacy and Chairman of the Food Fix Campaign, a non-profit focused on transforming our food policies.

T. D. Jakes, one of the world’s most revered communicators, leverages his pioneering vision and instinct to serve others in areas extending beyond the church. Throughout his life, T.D. Jakes has served and inspired people on a global scale, and his impact on the world goes far beyond the pulpit. More than just a spiritual leader, he is multi-dimensional, a real in-the-flesh renaissance man.

The T.D. Jakes Group is dedicated to solving society’s problems by building bridges and strategic partnerships that create equity and provide solutions for underrepresented and underserved communities. Through partnerships and disruptive thinking, The T.D. Jakes Group continues to make connections across sectors and stakeholders to create lasting, generational change and create a more equitable society. Around every corner, every initiative T.D. Jakes connects people from different walks of life across the globe.

As a Bishop, Jakes founded The Potter’s House, a non-denominational global church with 30,000+ members with campuses around the U.S. The Potter’s House reaches tens of millions. Bishop Jakes ministers to one of the most engaged audiences in the world. His trusted voice is heard in more than 80 million homes each day. By sharing practical applications of biblical truths accumulated during 45 years in ministry, he is a gateway for engaging and activating audiences around the globe.

An advisor to three U.S. Presidents, Jakes has been called “America’s Treasure” by Oprah Winfrey, “America’s Best Preacher” by TIME Magazine and is a master communicator for all ages. Bishop Jakes has been instrumental in growing the space for powerful faith-based content in the media and entertainment industry including: film, television, radio, publishing, podcasts, a self-titled talk show, and an award-winning music label. As an accomplished film producer, Bishop Jakes’ movies have grossed millions and catapulted the faith-based film industry to impressive heights.

A persuasive, thought-provoking and intersectional communicator, T.D. Jakes has more than 40 bestselling books in print, including New York Times bestsellers, Crushing, Instinct, Don’t Drop the Mic and soon-to-be-released Disruptive Thinking.

As a devoted husband to Serita Jakes of more than 35 years, the power couple has successfully raised five beautiful children, including Jamar Jakes, Jermaine Jakes, Cora Jakes, Sarah Jakes Roberts and Dexter Jakes.

Dean Kamen is an inventor, an entrepreneur, and a tireless advocate for science and technology. His roles as inventor and advocate are intertwined—his own passion for technology and its practical uses has driven his personal determination to spread the word about technology's virtues and by so doing to change the culture of the United States.

Dean Kamen is the founder and president of DEKA Research & Development Corporation. Examples of technologies developed by DEKA include the HomeChoice™ portable dialysis machine, the iBOT™ Mobility System, the Segway™ Human Transporter, a DARPA-funded robotic arm, a new and improved Stirling engine, and the Slingshot water purifier.

In addition to DEKA, one of Dean's proudest accomplishments is founding FIRST (For Inspiration and Recognition of Science and Technology), an organization dedicated to motivating the next generation to become science and technology leaders and build a better world. Founded in 1989, FIRST robotics programs have served more than 3.2 million young people, ages 4 to 18, in more than 100 countries around the globe. Alumni of life-changing FIRST programs gain access to exclusive scholarships, internships and other opportunities that create connections and open pathways to a wide variety of careers.

Kamen has received many awards for his efforts. Notably, Kamen was awarded the National Medal of Technology in 2000. Presented by President Clinton, this award was in recognition for inventions that have advanced medical care worldwide, and for innovative and imaginative leadership in awakening America to the excitement of science and technology. Kamen was elected a member of the National Academy of Engineering in 1997. He was awarded the Lemelson-MIT Prize in 2002, and was inducted into the National Inventors Hall of Fame in May 2005. He is a Fellow of the American Institute for Medical & Biological Engineering, as well as many other national and international engineering organizations.

Josh is the CEO of Worth Magazine where he oversees the overall strategic direction of the company while working closely with the management team to conceptualize and build scalable products and services.

A serial tech & media entrepreneur, Josh served as CEO of Techonomy Media, which was sold to Clarim Holdings, Worth's parent company, in 2018. At Techonomy, Josh spent 8 years driving sustainable business growth through strategic partnerships and new product development. He built Techonomy to be one of the leading media companies covering technology and its impact on business and society. Prior to Techonomy, Josh was the Chief Marketing officer of Transactis, an electronic billing & payments fintech company that was sold to Mastercard.

Josh sits on the board of Planet Reimagined, a non profit focused on climate advocacy started by multi-platinum artist Adam Met of AJR. He is a board member of various early stage tech companies, focused on helping them raise capital and build strategic partnerships.

Josh holds a MBA from Boston University and a BA from Brandeis University.

Dr. Kapp is a dynamic entrepreneur who has founded several healthcare start-ups, ranging from surgical centers and hospitals to electronic health record systems and medical real estate developments. He is passionate about introducing cutting-edge technology to enhance both the facilities and operations of healthcare organizations. As a board-certified orthopedic surgeon, former USAF Flight Surgeon, and type-rated jet aircraft pilot, Dr. Kapp has a unique combination of medical expertise and aviation knowledge.
Moreover, he is dedicated to advancing the new healthcare paradigm that focuses on the detection and reversal of asymptomatic diseases. Dr. Kapp is deeply committed to this cause and strives to improve patient outcomes by leveraging the latest advancements in medical technology and innovation.

2 x Grammy Winning/Multi-Platinum selling Pianist/Composer Peter Kater has been a leading innovator of contemporary instrumental music for 4 decades. He’s received many awards and accolades for his rich and diverse music including 14 Grammy Award nominations and two Grammy wins. He’s released over 70 critically acclaimed recordings and has scored the music for over 100 television and film productions including 11 On & Off-Broadway dramatic plays.

From solo piano and contemporary jazz ensembles to full orchestral works his cross-genre music is heard all over the world from the Olympics to Carnegie Hall. He is known for his many groundbreaking collaborations with musicians such as Native American flutist R. Carlos Nakai; Sting guitarist Dominic Miller and Sacred Chantress Snatam Kaur.

And as an avid environmentalist and humanitarian Peter is a proud recipient of the Environment Leadership Award from the United Nations.

Dr. Iya Khalil is the Vice President and Head of Data, AI & Genome Sciences at Merck charged with driving an AI-first data-driven approach to early discovery biology. Prior to Merck, she was at Novartis where she headed the 1st AI Innovation Lab in a major pharmaceutical company leading the development and application of best-in-class AI platforms and algorithms across discovery, translation, early research, clinical, and commercial.

Dr. Khalil has a doctorate in physics and is an AI pioneer with 20+ years of experience in AI and “big (& deep) data” for life sciences and healthcare. She is the co-founder and co-inventor of the proprietary AI engine that underpins Aitia bio, and is responsible for generating tremendous value by establishing and running key collaborations with pharmaceutical companies, foundations, payers, providers, and government agencies. She has extensive experience in developing AI algorithms and solutions across the continuum of Pharmaceutical R&D to healthcare, including drug discovery, drug development, clinical trials, real-world evidence, market access, and treatment algorithms for patients. Named to the PharmaVOICE 100 list of the most inspiring people in the life sciences industry for her ability to build bridges across the life science and healthcare industries, and for bringing people together to harness the power of computational modeling to change the lives of patients.

She serves as an advisor for the Bill and Melinda Gates Foundation in AgTech and is on the board of directors of Invaio Sciences, a Flagship Pioneering company in the agriculture biotech sector. Dr. Khalil is a frequent speaker at industry events and conferences and her work is featured in leading industry journals, and was recognized by then President Obama at a White House dinner as a leading entrepreneur in genomic medicine. She has been named to Inc magazine’s list of top female founders of 2018 and in Forbes’ 2019 top women-led startups “crushing tech.”

Justin Klee co-founded Amylyx Pharmaceuticals in 2013 and continues to serve as its Co-CEO and Co-Founder. Justin has overseen the development of Amylyx’s novel platform and therapeutic for neurodegenerative diseases from initial testing through clinical trials. Justin previously did research in neural systems while at Brown University and in neurophysiology and Alzheimer’s disease at Harvard Medical School. He received his Bachelor of Science in Neuroscience from Brown University.

Isaac “Zak” Kohane, MD, PhD, is the inaugural chair of Harvard Medical School’s Department of Biomedical Informatics, whose mission is to develop the methods, tools, and infrastructure required for a new generation of scientists and care providers to move biomedicine rapidly forward by taking advantage of the insight and precision offered by big data. Kohane develops and applies computational techniques to address disease at multiple scales, from whole health care systems to the functional genomics of neurodevelopment. He also has worked on AI applications in medicine since the 1990’s, including automated ventilator control, pediatric growth monitoring, detection of domestic abuse, diagnosing autism from multimodal data and most recently assisting clinicians using whole genome sequence and clinical histories to diagnose rare or unknown disease patients. His most urgent question is how to enable doctors to be most effective and enjoy their profession when they enter into a substantial symbiosis with machine intelligence. He is a member of the National Academy of Medicine, the American Society for Clinical Investigation and the American College of Medical Informatics.

SleepScore CEO Colin Lawlor is a sleep & wellness veteran and a passionate believer in the power of technology to connect dots and drive better health outcomes. Lawlor's career has spanned over 30 years, having worked at ResMed, BiancaMed and Bio-Medical Research Ltd., leading firms in the sleep science & wellness space. These opportunities have provided him with diverse experience in global consumer health & wellness, digital health, data science and e-commerce. As CEO, Colin leads SleepScore on its mission to leverage the most comprehensive and accurate data to advance the science and develop unique solutions that help millions of people around the world to improve their sleep. SleepScore entered the Deloitte Fast 500 at position 105 in 2022 and also entered the Inc 5000 fastest growing companies in the United States. Originally from Ireland and a graduate of Trinity College Dublin, Colin started his working life at a certain global brewing company. He is keenly aware that while a pint of Guinness may be “good for you,” having one too many will definitely impact your sleep.

Peter Lee is President, Microsoft Research, leading research across 14 worldwide laboratories. He is a member of the National Academy of Medicine and serves on the boards of several institutions in AI and medicine, including the Board of Trustees of the Mayo Clinic and the Board of Directors of the Kaiser Permanente School of Medicine. Under President Obama, he was a Commissioner on Enhancing National Cybersecurity. In 2023, he coauthored “The AI Revolution in Medicine, GPT-4 and Beyond” and hosted the podcast series “The AI Revolution in Medicine, Revisited.” a follow-up to the book. He was named by Time magazine in 2024 as one of the 100 most influential people in health and life sciences.

Admiral Rachel L. Levine serves as the 17th Assistant Secretary for Health for the U.S. Department of Health and Human Services (HHS) and the head of the U.S. Public Health Service Commissioned Corps. She fights every day to improve the health and well-being of all Americans. She’s working to help our nation overcome the COVID-19 pandemic and build a stronger foundation for a healthier future - one in which every American can attain their full health potential. ADM Levine’s storied career, first, as a physician in academic medicine focused on the intersection between mental and physical health, treating children, adolescents, and young adults. Then as Pennsylvania’s Physician General and later as Pennsylvania’s Secretary of Health, she addressed COVID-19, the opioid crisis, behavioral health and other public health challenges.

Ellen is Managing Director of Silicon Valley Connect, working with organizations and entrepreneurs on opportunities for technology-driven innovation, while also managing a portfolio of 60+ startups as an angel investor/advisor. She is a member of the Board of Directors at commercial real estate finance company Walker & Dunlop (WD), social network for military and veterans company Rallypoint, private capital markets data & analytics platform Aumni, and fintech platform for alternative assets company CAIS. She is a Senior Advisor to the President at Arizona State University, named the “most innovative” university by US News & World report eight years and counting.

Ellen spent nearly a decade working with LinkedIn, including heading up Corporate Development & Strategy and member of the Executive Team following her original role as Advisory Board member at the company’s founding. Over her career, Ellen has held formal roles in venture capital (Softbank; NeoCarta; DFJ), startups (WhoWhere, bought by Lycos; Softbook Press, bought by Gemstar TVGuide; LinkedIn, bought by Microsoft), technology think tanks (Interval Research), large corporations (Apple; PriceWaterhouse Coopers), non-profits (Child Family Health International; MIND Institute) and universities (Harvard; Stanford; Arizona State University).

Described as the “Most Connected Woman in Silicon Valley", and named one of the “Top 25 Female Early Stage Investors”, Ellen now spends much of her time focused on dynamic, rapidly-growing startups, on issues related to the “Future of Work” (automation, AI, skills training, and education) and businesses helping society respond to the post-pandemic world.

She has a BS from the University of Michigan, and MA/PhD in Cognitive Psychology from Stanford University.

William W. Li, MD, is an internationally renowned physician, scientist and author of the New York Times bestseller “Eat to Beat Disease: The New Science of How Your Body Can Heal Itself.” His groundbreaking work has led to the development of more than 30 new medical treatments and impacts care for more than 70 diseases including cancer, diabetes, blindness, heart disease and obesity. His TED Talk, “Can We Eat to Starve Cancer?” has garnered more than 11 million views. Dr. Li has appeared on Good Morning America, CNN, CNBC, Rachael Ray, Live with Kelly & Ryan and many more, and he has been featured in USA Today, Time Magazine, The Atlantic, O Magazine and more. He is president and medical director of the Angiogenesis Foundation and is leading research into COVID-19. His newest book, “Eat to Beat Your Diet: Burn Fat, Heal Your Metabolism, and Live Longer” will be released March 21, 2023.

Dan Liljenquist is the Senior Vice President and Chief Strategy Officer for Intermountain Healthcare. As a member of the Intermountain Executive Leadership Team he is responsible for guiding the process of setting and achieving the organization’s strategic priorities, as well as overseeing Intermountain’s Strategy, Corporate Development, Government Relations, and Care Transformation and Information Systems teams. Prior to joining Intermountain in 2012, Dan served in the Utah State Senate and was nationally recognized for his work on Medicaid and public-sector pension reforms.

In 2021, he was recognized by Modern Healthcare as one of the “100 Most Influential People in Healthcare” and as one of the “Top 25 Innovators in Healthcare.” He also was featured by Modern Healthcare in “The Collaborative: 45 healthcare leaders who exemplify collaboration created in service to the patient.”

Dan began his career as a consultant at Bain & Company before joining Affiliated Computer Systems to lead operational strategy for its commercial solutions division. He also served as president and chief operating officer of FOCUS Services LLC, a direct sales support and call center services provider.

Dan is the architect and current board chair of Civica Rx, an initiative launched in 2018 to create a not- for-profit generic drug company to ensure that essential generic medications are available and affordable to everyone. After growing to include 55 health systems as members of Civica Rx and producing and distributing approximately 60 medications, the company announced in February 2022 that it would begin producing and distributing affordable insulin in 2024. Dan is the lead author of Addressing Generic-Drug Market Failures – The Case for Establishing a Nonprofit Manufacturer, published in the New England Journal of Medicine in May 2018. In 2021, Dan also helped launch and currently serves as board chair of Graphite Health, a member-led, non-profit company intent on making healthcare data interoperability easy and affordable, and facilitating the rapid adoption of digital health solutions.

Dan received his Juris Doctorate from The University of Chicago Law School and his Bachelor of Arts in Economics from Brigham Young University. Dan and his wife, Brooke, are the parents of six children and reside in Bountiful, Utah.

Shelley Lyford is CEO and Chair of the West Health Institute and CEO, Chair and Trustee of the Gary and Mary West Foundation, a private foundation that has awarded more than $550 million in grants for aging and healthcare programs and initiatives since its inception in 2006. Lyford has been with the organization for nearly two decades and has been serving as its CEO since 2012.

Key initiatives under Lyford’s leadership include the creation of the West Health Accelerator at Mass General Brigham, a $16.4 million, multi-year effort to help transform care for older adults in the hospital and the West Health Accelerator at Northwestern Medicine, which integrates behavioral health services into primary care settings to promote earlier intervention and increase access to care. The West Health Accelerator is creating scalable blueprints for adoption by other health systems and hospitals throughout the nation to transform the future of healthcare.

In 2019, Lyford was appointed as a commissioner on the California Commission on Aging, advising the state’s governor and legislature, along with federal, state and local agencies, on issues, policies and regulations that affect California’s seniors. Subsequently, she was appointed to California’s Master Plan for Aging Stakeholder Advisory Committee. Prior to these appointments, Lyford played a critical role in launching a statewide public awareness campaign called “We Stand With Seniors,” which brought aging to the forefront of the 2018 California gubernatorial race and led to the creation of California’s first Master Plan for Aging. West Health continues to support the development of multi-sector plans for aging in more than 20 other states. In 2022, Lyford received the prestigious American Society on Aging Award for outstanding contributions to aging-related research, administration and advocacy.

Lyford is vice-chair of the board of directors of CivicaRx, the nation’s first not-for-profit generic drug company and serves as a director on several boards including the San Diego Economic Development Corporation Board and the Community Board of UC San Diego Health.

Karen S. Lynch is president and chief executive officer of CVS Health®, the leading health solutions company and ranked fourth largest on the Fortune 500. Karen leads more than 300,000 colleagues who are passionate about delivering a superior health care experience for consumers by improving health outcomes, broadening access to care and lowering costs.

Under Karen’s leadership, CVS Health touches the lives of more than 100 million people through its health care benefits and pharmacy benefits management businesses, and presence in over 9,000 community health destinations across the United States. As part of the company’s commitment to sustainability, Karen has set bold goals to advance health equity and ensure a healthier planet for the people and communities CVS Health serves.

Karen has over three decades of experience in the health care industry. Prior to becoming chief executive officer in February 2021, Karen was executive vice president of CVS Health and president of Aetna®, where she was responsible for delivering consumer-centric, holistic health care to the millions of people Aetna serves.
Before joining CVS Health, Karen held executive positions at Cigna® and Magellan Health Services, where she served as president. She began her career with Ernst & Young as a certified public accountant.

Karen has been named to Fortune’s list of the “50 Most Powerful Women in Business” the past six years, including the top ranking in 2021 and 2022. In 2022, Fortune named Karen the Most Inspirational CEO. She was included on the Bloomberg 50 list of people who have changed global business and Forbes’ inaugural “50 Over 50” list. She has received many other awards and recognition for her achievements in health and business.

Karen is a member of the Business Roundtable, the World Economic Forum Global Coalition for Value in Healthcare Executive Board and the Boston College Women’s Council. Previously, she served on the board of U.S. Bancorp and as a trustee of The Bushnell Center for the Performing Arts in Hartford.

A graduate of Boston College and The Questrom School of Business at Boston University, Karen was awarded an honorary Doctor of Commercial Science from the University of Hartford in 2022 and an honorary doctorate of humane letters from Becker College in 2015.

Poonacha Machaiah is the Co-Founder and CEO of Cyberhuman.ai, a pioneering agentic AI platform focused on personalized well-being, merging cutting-edge technology with integrative and lifestyle medicine. He is also the co-founder of Peak Living, a longevity and vitality services initiative and Chief of AI and technology at the ‘House of Epigenetics’ – ABChopra venture. These initiatives have been in collaboration with world-renowned integrative medicine expert Deepak Chopra, MD.

Previously, Poonacha served as the CEO of The Chopra Foundation, where he led global initiatives to advance mental health, societal well-being, and environmental sustainability and continues to server as the strategic advisor. He is the founding member of the Global Mental Health Task Force, focused on UN SDGs. Poonacha’s leadership has driven powerful initiatives such as NeverAlone, which addresses mental health and suicide prevention.

His career spans key roles as a technology leader at Nortel, Iridium, Motorola, and Sasken, where he contributed to pioneering innovations across global markets. He holds an MBA from the College of William and Mary, Bachelor of Science in
Computer Science and Engineering and pursuing a Doctoral Degree in Public Health at Claremont graduate University.

With a deep commitment to human potential and conscious innovation, Poonacha continues to shape the future of wellness through visionary leadership at the intersection of science, technology, and purpose.

Mr. MacMillan was named President and CEO of Hologic, the global leader in Women’s Health, in December 2013 and appointed Chairman in June 2015. Under his leadership at Hologic, the company has more than doubled in revenue by expanding its leading positions in 3-D mammography, molecular diagnostics (including launching its leading COVID-19 test) and expanded its gynecological surgical business.

Stephen P. MacMillan was Chairman, President and Chief Executive Officer of Stryker Corporation until February 2012. Mr. MacMillan joined Stryker in 2003 as President and Chief Operating Officer, was appointed CEO effective January 2005, and Chairman in January 2010.

During his 9 years at Stryker, revenues almost tripled from $2.8B to over $8.3B in 2011, and the company moved up over 200 spots on the Fortune 500 list while transforming the company’s quality, compliance, and manufacturing operations.

Mr. MacMillan began his career with Procter & Gamble in 1985 and later spent 11 years with Johnson & Johnson in both the U.S. and Europe and became President of the joint venture between Johnson & Johnson and Merck.

In 2000, he joined Pharmacia Corporation’s Executive Committee, reporting to CEO Fred Hassan, where he oversaw five global businesses with revenues exceeding $2 billion.

Mr. MacMillan has also served on the Board of Directors of Texas Instruments, Alere and Boston Scientific and served on the Institute of Medicine’s Healthcare Policy Roundtable. He was also one of the Fortune 500 CEOs appointed to the Department of Commerce’s Advanced Manufacturing Partnership to help the country rebound from the 08/09 downturn*. Mr. MacMillan currently serves on the Board AdvaMed (the medical device industry’s trade association).

He received a Bachelor of Arts degree in Economics from Davidson College and is a graduate of Harvard Business School’s Advanced Management Program. He is married and has four children.

As the Chairman of the Mandela Legacy Foundation, Zondwa has a unique understanding of sustainable social intervention and inherited the responsibility of continuing a lifelong pursuit of equality, human rights and equal opportunity for all.
Mandela Legacy Foundation strives to create unlikely collaborations that span industry sectors, catalyse and scale transformative innovation and take risks others cannot - or will not - take.

Our mission has been to develop solutions to tackle unemployment and implement programs that support generations. As such, the Mandela Legacy Foundation’s immediate focus is to create a future for Africa’s youth by providing hope, guidance and most importantly– opportunity, through the creation of jobs.
To date, the Mandela Legacy Foundation’s partnerships has created more than 25,000 jobs and trained over 200,000 youth from marginalised communities across Africa.

This year, the Foundation has launched the 'Global Internship Challenge' - a worldwide initiative to create one million internship placements around the world by 2030 - in response to the growing unemployment crisis of tertiary-educated graduates.

Dr. Masiakos is a pediatric surgeon at MGH, Director of the pediatric trauma surgery service. As injury prevention advocate, he has aided in the development of dozens of state injury prevention laws. His role in injury prevention has extended into the community through outreach programs that have positively impacted child wellness to provides health care access to those in need. He has written multiple manuscripts on injury prevention including one in The New England Journal of Medicine titled “The Quiet Room” that served as a call to action for organized medicine to embrace gun violence as a public health crisis. Using his 30-year experience, Dr. Masiakos established the Mass. General Center for Gun Violence Prevention. His long-term goal is to decrease unintentional morbidity and mortality associated with firearm injuries.

The Honorable Denis Richard McDonough was nominated by President Biden to lead the Department of Veterans Affairs. Mr. McDonough’s nomination was confirmed by the United States Senate on February 8th, 2021, and he was sworn in the following day as the 11th Secretary of Veterans Affairs. On January 27, 2021, during his confirmation hearing, Secretary McDonough testified to Congress, “I will work tirelessly to build and restore VA's trust as the premier agency for ensuring thewell-being of America’s Veterans. After all, there is no more sacred obligation nor noble undertaking than to uphold our promises to our Veterans, whether they came home decades ago or days ago.” Secretary McDonough served in the Obama Administration as the 26th White House Chief of Staff from February 2013 to January 2017. In that role, Mr. McDonough managed the White House staff and worked across the cabinet to advance the Obama-Biden agenda, confronted management issues facing the federal government, and devised and enforced goals, plans, and performance standards to preserve the Obama-Biden Administration’s reputation for effective, ethical operations. Prior to his role as Chief of Staff, Mr. McDonough was Principal Deputy National Security Advisor from October 2010 to January 2013. He also served as the Chief of Staff of the National Security Staff and as the Deputy National Security Advisor for Strategic Communications. He chaired the National Security Council’s Deputies Committee, leading the multiagency team to address complex challenges including crisis management and national security policymaking. And throughout his service in the White House, Secretary McDonough helped lead the Obama-Biden administration’s work on behalf of military families and Veterans. Before his eight-year tenure in the White House, Secretary McDonough served in senior leadership and policymaking positions in the U.S. House of Representatives as a Professional Staff Member on the International Relations Committee and in the U.S. Senate for Majority Leader Tom Daschle and Senator Ken Salazar. Since his White House tenure, Secretary McDonough was Professor of the Practice of Public Policy at the Keough School of Global Affairs at the University of Notre Dame, Senior Advisor and Senior Principal at the Markle Foundation, and on the board of directors of the National Democratic Institute, the Tent Partnership for Refugees, and the SAFE Project, a national nonprofit working to end the nation’s catastrophic addiction epidemic. Secretary McDonough grew up in Minnesota in a family of 11 children, graduated from St. John's University in Collegeville, Minnesota, and earned his master's degree from Georgetown University. Secretary McDonough and his wife, Kari, have three children.

Jane Metcalfe is the CEO and founder of proto.life, a weekly newsletter, website, book, and events company tracking how digital tools and an engineering mindset are revolutionizing human biology. She is chair of the Human Immunome Project, a global non-profit working to decode the immune system in order to transform how we prevent, diagnose, and treat disease. She is also co-chair of the Futures Council of the Focused Ultrasound Foundation and advises various startups.

Prior to that, Metcalfe made chocolate on a pier in San Francisco as the President of TCHO Chocolate, whose TCHO Source program has transformed the lives of cacao farmers in Latin America and Africa.

She is probably best known for her role as the co-founder and former president of Wired Ventures, Inc., a diversified media company whose businesses included Wired Magazine (US, UK, and Japanese editions), Wired Digital, and Wired Books. Metcalfe is an entrepreneur, editor, publisher, investor, and advisor, experienced in harnessing new ideas to create strong brands, rapidly grow businesses, and lead healthy, creative, mission-driven organizations. She was recently honored with a Webby Award for Lifetime Achievement.

Jamie Metzl is one of the world’s leading technology and healthcare futurists and strategists, Founder and Chair of the global social movement OneShared.World, a Senior Fellow of the Atlantic Council, a faculty member of NextMed Health, and a Singularity University expert. He appears regularly on national and international media and his syndicated columns, podcasts, and interviews on AI, science, technology, and global affairs have reached hundreds of millions of people across the globe. Jamie is the author of six books, including the newly-released Superconvergence: How the Genetics, Biotech and AI Revolutions Will Transform Our Lives, Work, and World, the international bestseller, Hacking Darwin: Genetic Engineering and the Future of Humanity, and the sci-fi thrillers Genesis Code and Eternal Sonata. His new books, The AI Ten Commandments and Virtuosa, will both be released in 2026. In 2025, Jamie was appointed as a Commissioner of The Lancet Commission on Precision Medicine, which will over the next four years develop a definitive report on the future of technology-enhanced healthcare. Jamie previously served in the U.S. National Security Council, State Department, and Senate Foreign Relations Committee, with the United Nations in Cambodia, and on the World Health Organization expert advisory committee on human genome editing. A former partner in a global private equity firm, he sits on advisory boards for multiple biotechnology and other companies and co-established the WisdomTree BioRevolution Exchange Traded Fund (ticker: WDNA). Jamie holds a Ph.D. from Oxford, a law degree from Harvard, and an undergraduate degree from Brown and is an avid ironman triathlete and ultramarathon runner.

Valerie Montgomery Rice, M.D., FACOG, is President and CEO of Morehouse School of Medicine (MSM), where she advances health equity through education, research, clinical care, and community engagement. A renowned infertility specialist and researcher, she became the first woman to lead MSM in 2014 after joining as Dean and Executive Vice President in 2011.

Under her leadership, MSM has expanded degree programs, strengthened research capacity, and secured record philanthropic support, including a $175 million gift from Bloomberg Philanthropies. She has forged national partnerships, enhanced enrollment, and launched initiatives with lasting impact on health equity.

Dr. Montgomery Rice serves on the boards of UnitedHealth Group, Nemours Health Foundation, Georgia Power, and previously on the boards of 23andMe, Moffitt Cancer Center, and Wellpath. An elected member of the National Academy of Medicine, she advises nationally on health policy, diversity in the biomedical workforce, and innovation in medical education.

She earned her M.D. from Harvard Medical School, completed her OB/GYN residency at Emory University, and her fellowship in reproductive endocrinology and infertility at Hutzel Hospital in Detroit. She holds honorary degrees from multiple institutions and is a sought-after keynote speaker on leadership, workforce development, and health equity.

Freddie Moross is Managing Director of Myndstream, a leading wellness brand focussed on elevating audio quality in key therapeutic and healthcare environments. Myndstream have recently launched a streaming service for spas, which leverages their position as part of Cutting Edge Group, who have 20 years experience as the leading international full-service provider of music for film, television, advertising and gaming.

Alan Murray is CEO of Fortune Media, where he oversees all of the company’s operations. He writes a closely-read newsletter, the Fortune CEO Daily, and cohosts a weekly podcast, Leadership Next. He is the author of five books, including most recently Tomorrow’s Capitalist: My Search for the Soul of Business. Prior to joining Fortune in 2015, Murray led the Pew Research Center. Before that, he was at the Wall Street Journal for many years, serving as Deputy Managing Editor, Executive Editor Online, Washington Bureau Chief, and author of the Political Capital and Business columns. He also served for a time as Washington bureau chief of CNBC, and co-host of the network’s Capitol Report.

Laura Newinski is the Deputy Chair of the board of directors and the Chief Operating Officer of KPMG, LLP. Laura chairs the U.S. Management Committee and is responsible for the development and execution of the U.S. firm’s strategy and priorities. Laura is also a member of both KPMG’s global Board of Directors and global Executive Committee.

Laura is recognized for her insights on business strategy, operations, talent, culture and tax, as well as her unwavering commitment to quality and integrity and focus on building strong, diverse and inclusive teams.

Laura has been instrumental in shaping KPMG’s investments in cutting-edge technologies, including generative AI and the establishment of the firm’s AI and Disruptive Technology unit which has positioned KPMG as a leader in the evolving landscape of artificial intelligence. Her leadership has led advancements to how we service our clients, the capital markets and in KPMG’s digital transformation, data strategy, and technology operations. Overall, this has resulted in significant gains in client and employee experience, productivity, and cost-efficiency.

Laura led the development of KPMG’s Lakehouse, a $450M state-of-the-art training facility and cultural home located in the heart of the Lake Nona region. Lakehouse serves as a hub for collaboration, innovation, and education, underscoring her vision for creating impactful investments that foster growth and connectivity. Laura’s passion for health and wellness is reflected in her role as executive sponsor for key healthcare clients and in her sponsorship of KPMG’s initial engagement in the Lake Nona Impact Forum in 2017.

Laura’s client service roles have focused on both publicly held and large private companies. Her account leadership roles have focused on many of the firm’s largest accounts across all sectors.

Laura is a frequent speaker on cultivating an inclusive culture and has championed inclusion and equity in education and health care through her board and philanthropic activities.

Laura holds a B.B.A. degree in accounting from the University of Iowa and a M.B.T. degree from the University of Minnesota’s Carlson School of Management. She is a licensed CPA in Florida, New York and Minnesota and is a member of the American Institute of Certified Public Accountants, the New York State Society of CPAs and the Minnesota Society of Certified Public Accountants

Cathy is a veteran entertainment journalist, event producer and entrepreneur. She is the founder of Hollywood & Mind, a first-of-its kind venture focused on leveraging the unique and unparalleled influence of the entertainment industry to elevate mental health and save lives.

“I believe music starts when we are conceived,” Pereira says. “It runs in our veins.” It certainly did in the musical Brazilian home of his childhood and followed him as he played guitar with some of the country’s legendary jazz musicians, including Ivan Lins. As a guitarist, Pereira played with the English soul band Simply Red throughout the early ’90s, leading up to his now ongoing career in film music. In 1997, Pereira was commissioned for a song for James Brooks’ Oscar-nominated comedy, As Good as It Gets—and discovered his melodies belonged in films.

Heitor Pereira’s original film scores range from blockbuster family hits, such as the Despicable Me, Smurfs, Angry Birds, and Curious George franchises, to acclaimed dramas to such as If I Stay, A Little Bit of Heaven, and Dirty Dancing: Havana Nights, to romantic comedies including It’s Complicated and The Valet. Pereira’s most recent work includes the box office smash Minions and Minions: The Rise of Gru, Paw Patrol: The Movie, My Little Pony: The Next Generation, and Puss in Boots: The Last Wish. Pereira’s film scores have garnered critical acclaim and accolades, including Annie Award nominations for Despicable Me and Despicable Me 2, a Hollywood Music in Media Award nomination for Puss in Boots: The Last Wish, as well as ASCAP Film & TV Music Awards. In 2017, Pereira won the Emmy for Outstanding Music and Sound for his work on Sonic Sea, the NRDC-sponsored documentary about the impact of man-made sound on ocean life.

Jonathan B. Perlin, MD, PhD became the seventh President and CEO of The Joint Commission Enterprise on March 1, 2022. The Joint Commission Enterprise includes The Joint Commission, Joint Commission Resources (JCR), Joint Commission International (JCI) and the National Quality Forum (NQF).

Previously, as President, Clinical Operations and Chief Medical Officer, HCA Healthcare, Dr. Perlin led clinicians, data scientists and researchers in developing a learning health system model for improving care at the system’s 189 hospitals and 2,200 other locations. His team’s work achieved national recognition for preventing elective pre-term deliveries, reducing maternal mortality, using artificial intelligence to improve sepsis survival, and developing public-private-academic partnerships for improving infection prevention and treating COVID-19. Dr. Perlin’s CHARGE consortium partnered HCA, the Agency for Healthcare Research and Quality (AHRQ) and academia to create a reusable platform for accelerated research using real-world evidence from the care of over 400,000 COVID inpatients.

Before HCA, Dr. Perlin was Under Secretary for Health in the U.S. Department of Veterans Affairs (VA), where he led the Veterans Health Administration (VHA) to national prominence for full implementation of a national electronic health record and benchmark clinical performance. He has served on numerous Federal Commissions including as a Congressional Budget Office Health Advisor, a member of MedPAC (Medicare Payment Advisory Commission), and as chair of the VA Special Medical Advisory Group. An elected member of the National Academy of Medicine (NAM), he has co-chaired NAM action collaboratives on digital health, combatting opioids and climate change.

Dr. Perlin’s board service includes Columbia University’s Health Policy and Management program, Vanderbilt University’s School of Engineering, and he served as a Trustee of Meharry Medical College for 15 years. Perennially recognized as one of the most influential leaders in healthcare, Dr. Perlin maintains faculty appointments at Vanderbilt University as a Clinical Professor of Medicine and at Virginia Commonwealth University as an Adjunct Professor of Health Administration.

Ms. Peterson joined Clayton Dubilier & Rice (CD&R) as an operating partner in 2019, where she spans consumer and healthcare investing and spearheads the firm’s efforts to creating technology and digital capacity to support its investments and portfolio companies. Prior to CD&R, she was group worldwide chairman of Johnson & Johnson, where her portfolio included medical devices, consumer, global operating infrastructure, technology, supply chain and key strategic initiatives. Previously, Ms. Peterson served as Chairman & CEO of Bayer CropScience AG, CEO of Bayer Medical Care, and president of Bayer HealthCare AG’s Diabetes Care Division. She started her career at McKinsey and has held executive positions at Medco Health Solutions (formerly known as Merck-Medco), Nabisco, and Whirlpool. Ms. Peterson is the lead independent director of the Microsoft board of directors, chairman of the board of the American Academy in Berlin, serves as international advisory board member to global strategic advisory firm Hakluyt & Company, and is on the board of the Institute for Advanced Study, the world- renowned center for science and humanities research in Princeton, NJ. Ms. Peterson is also Executive Chairman of Volastra, an early-stage life science company.

Previously, Peterson was chairman of EcoHealth Alliance, the world’s foremost global institution at the forefront of pandemic detection and mitigation. She was also a member of the board of directors of The Dun & Bradstreet Corp. where she chaired the Innovation & Technology Committee. She has appeared on FORTUNE Magazine’s list of Most Powerful Women numerous times and was featured on the Magazine’s inaugural list of Leaders Who Are Changing Healthcare. Ms. Peterson attended Princeton University (M.P.A., Applied Economics), and Cornell University (B.A., Government).

Joe Petro assumed the role of executive vice president and chief technology officer in September 2018. He is responsible for overseeing research, platform development, application development, dev ops, and cloud readiness for the company.

Joe joined Nuance in 2008 as senior vice president of healthcare research and development, having previously served as senior vice president of product development at Eclipsys Corporation, where he oversaw the development of more than 30 solution sets spanning diverse healthcare environments. Over the course of his career, he has held a number of executive roles both in venture?backed startups and large?scale enterprises.

Joe holds a BS in mechanical engineering from the University of New Hampshire and an MS in mechanical engineering from Kettering University.

Stephen Quake is Head of Science at the Chan Zuckerberg Initiative, where he oversees CZI’s science grant programs, technology development, and the CZ Biohub Network. He has received numerous awards for his contributions to science and is one of only two dozen scientists elected to all three National Academies. Steve also holds a faculty position at Stanford University, where he is the Lee Otterson Professor of Bioengineering and Applied Physics. Previously he was the founding co-president of the Chan Zuckerberg Biohub (2016-2022), investigator of the Howard Hughes Medical Institute (2006-2016), and professor at the California Institute of Technology (1996-2005).

As the Co-Founder and CEO of Manna Tree, Ellie is a passionate investor focused on improving human health. Manna Tree invests in growth stage businesses transforming the food supply chain for healthier outcomes. Ellie is a member of the firm’s Executive and Investment Committees. She shapes the firm’s vision strategy and investment products and develops Manna Tree’s global network. For the past 10 years, Ellie has studied the evolution of the food and beverage supply chain, as well as the increasing consumer demand for healthier alternatives. In addition to her role at Manna Tree, Ellie is an active philanthropist. Through her family office, Mission: Ingredients, Ellie drives positive change in global population health. She supports ingredient research, outdoor wilderness, youth education, and military health and recovery programs. Ellie earned her bachelor’s degree in sociology from Harvard University, where she was a varsity ski racer. She earned her master’s degree in agriculture economics from Purdue University and her MBA in agribusiness from Indiana University’s Kelly School of Business, where she was a Tobias Fellow.

Dr. Jennifer Schneider is the co-founder and chief executive officer of Homeward, a company focused on rearchitecting the delivery of health and care in partnership with communities everywhere, starting in rural America. Having grown up in a small town, and being diagnosed with type 1 diabetes at a young age, she experienced first-hand the challenges of accessing convenient care that millions of families across rural America deal with everyday. This fueled her passion to found Homeward and create novel, value-based care models that are purpose built to address the needs of rural Americans.

Previously, Dr. Schneider served as the chief medical officer and president of Livongo. While there, she led the company through the largest consumer digital health Initial Public Offering in history and the industry’s largest merger ever between Livongo and Teladoc Health, valuing Livongo at $18.5 billion. She also served as chief medical officer of Castlight Health.

Dr. Schneider has been honored by Modern Healthcare as one of the “100 Most Influential People in Healthcare” and by Fierce Healthcare as a “Woman of Influence” for her work empowering women and modeling diversity and inclusion in the workplace. Dr. Schneider is also on the boards of Cityblock, Maven, and Jasper.

Dr. Schneider completed her bachelor's degree in biology at the College of the Holy Cross. She went on to get her MD at The Johns Hopkins University School of Medicine and her master’s degree in Health Services Research at Stanford University.

Ash is a Principal at KPMG serving as the National Healthcare Industry Leader. He leads KPMG’s work in healthcare across the Audit, Tax, and Advisory functions for the U.S. market and the Americas region. Ash also supports several Audit Committees across the industry and advises senior leaders and Boards on industry trends and strategies.

Ash is a highly experienced healthcare professional at the cutting edge of information technology (IT) advances in the sector. In a career spanning over 35 years, he has worked for some of the world’s leading IT and consulting firms, using technology to drive improvements such as telemedicine, e-commerce, membership systems, customer service and healthcare management.

Ash has a proven track record in leading teams to develop long-term client relationships and deliver innovative, compelling, and transformational solutions across the healthcare ecosystem. He builds strong and collaborative teams with an aligned mission to deliver customer excellence and sustainable growth.

As Senior Executive Director Healthcare for Americas with Cisco, he was responsible for payers, providers and life sciences accounts including the Mayo Clinic, WellPoint, Cigna, Wellcare, Medtronic and Kaiser. He led the development and deployment of telemedicine solutions with key clients and government agencies.

Prior to this, Ash was Vice President Health Solutions for Wellpoint, supporting over 32 million members (one in 10 Americans) in enterprise applications. He also held senior positions with KGT Global Technologies, IBM and Accenture, leading executive teams in the U.S. and around the world through major change programs in hospitals, medical service providers, physician group practices and managed care organizations.

Ash’s breadth of experience is typified by his first two roles: first as owner of his own consulting and medical management business, and then with The University of Cincinnati Medical Center in the U.S., where he was a hospital administrator leading several departments including Radiology, Nuclear Medicine, Lab Medicine, Managed Care, Cancer and Pharmacy.

Alyson Shontell joined Fortune in October 2021 as Editor-in-Chief and Chief Content Officer. In her role, she oversees all content across Fortune’s platforms including the magazine, website, newsletters, executive conferences, videos, podcasts, and Fortune Connect. Her appointment made her the first woman and youngest editor to helm Fortune’s 92-year-old newsroom. She previously served as editor-in-chief of Business Insider, a publication she helped launch in 2008, where she oversaw award-winning journalism. She serves as a judge for the ASME and Loeb Awards.

JSM is a global commercial music production leader for the world's most influential and compelling brands. Located in its beautiful, newly completed 10,000 sq. foot facilities in NYC’s Financial District, JSM is one of the world’s most comprehensive recording and creative resources boasting a full staff of composers and arrangers. Embracing new ideas and technologies, with the goal of working towards powerful creative and quantifiable solutions for its clients, JSM has paved the way in musical equities and sonic branding.

Led by CEO and CCO Joel Simon, JSM is the most awarded music production in the world with collaborations have been awarded 92 Cannes Lions including several of the coveted Titanium, Grand Prix, Glass & Integrated. JSM recently won the 2020 Emmy Award for Outstanding Commercial for Sandy Hook Promise “Back-To-School Essentials”. Additionally JSM has won 2022 LIA GLOBAL Radio & Audio Company of the year, 2022 North American Music & Sound Company, 2022 North American Radio and Sound Company of the year, dozens of Clio’s, sports Clio’s, The 2020 Grand Clio for Storytelling, The 2016 Super Clio, 32 AICP, Webby Awards, Cresta and Immortal Awards, 26 Addy’s, Andys, One Show, Gold AdAge Hispanic Creative Advertising, and a dozen Shots Awards.

A former Crain’s Business 40Under40 honoree, Simon has judged work for the global advertising and music industries; LIA, Music + Sound, Cannes, Clio, Webby, Advertising Week, Billboard Music Conferences and The AICP.

Robin L. Smith, MD, MBA is a global business leader, medical doctor, author and entrepreneur in the healthcare industry. She is a trailblazer in regenerative medicine and predictive analytics and has focused on turnarounds, M&A and disruptive innovations driving interest and growth. Dr. Smith received her B.A. from Yale University and her M.D. from the Yale School of Medicine. She holds an M.B.A. from the Wharton School of Business, completed the Stanford University Directors Program and received an honorary Doctor of Science degree from Thomas Jefferson Medical College. A thought leader in health, Dr. Smith addressed diverse audiences in interviews and talks at prestigious venues such as the Future Investment Initiative, the Lake Nona Impact Forum and the Vatican, and participated in numerous scientific conferences.

Dr. Smith is also active in many nonprofit organizations. She founded the Cura Foundation in 2007, a nonsectarian public charity dedicated to improving human health and well-being and increasing quality of life globally. As president and chairman of the board, Dr. Smith led the Cura Foundation through successful events and partnerships, having worked with amazing individuals and institutions, including the Vatican to educate, accelerate innovation and create the #UniteToPrevent and #UniteToCure movement.

Paul Stamets, speaker, author, mycologist, medical researcher and entrepreneur, is considered an intellectual and industry leader in fungi: habitat, medicinal use, and production. He lectures extensively to deepen the understanding and respect for the organisms that literally exist under every footstep taken on this path of life. Paul is the author of six books and has discovered and named numerous new species of psilocybin mushrooms.

Taura Stinson is an Academy/Golden Globe Award Nominated songwriter! Her ability to conclusively tell stories in a wide range of artistic mediums is a trait that she attributes to her roots in both Birmingham, Alabama and Oakland, California. Now based in Los Angeles, Ca, Taura is continuing to write heart forward songs for tv & film, scripts, and books centered on social injustice, climate change, the power of love and the magic of manifestation. Her personal mantra “Believe-Become” has been shared by millions of people around the globe, as has her music, which includes songs recorded by Destiny’s Child, Kelis, Solange Knowles, Kanye West, Mary J. Blige, Earth Wind & Fire, Brandy Norwood, Usher, Steven Tyler, Jennifer Hudson, Nas and many more. Her most recent work includes Don’t Look Up and Carmen, with frequent collaborator Nicholas Britell and Marvel’s Moon Girl and Devil Dinosaur with longtime collaborator Raphael Saadiq. She also won various awards including a Critics Choice Award for “Best Song in a Documentary” and her first independently published book, ‘100 Things Every Black Girl Should Know’ received the “In the Margins Award” for At-risk youth, presented by librarians across northern America. Taura second book, “100 Ways To Love Yourself: Inside and Out’ was released February 2020. It's a modern self-improvement book where the teacher is also the student. She is also composing for film/tv and experimenting with new ways to marry words and sounds in a way that uplifts, enlightens and empowers.

Noor is the Founder and Managing Partner of Global Ventures, a UAE-based, Series-A focused, emerging-market venture capital firm with presence in Egypt, Saudi Arabia and Nigeria. With $200 million AUM, and financial returns rating it as a top decile fund, Global Ventures has become a leading investor across the Middle East and Africa.

Since its inception in 2018, Global Ventures has completed 50 investments across ten markets, deliberately focused on sectors positively affecting millions of lives across the world, such as FinTech, Digital Health, EdTech and AgriTech. In addition to generating top decile returns, the portfolio has had a demonstrable impact on millions of lives through its company founders creating 7,200 jobs, enabling female leadership, powering financial inclusion for over 27 million people and expanding healthcare access to over 4 million patients.

Prior to Global Ventures, Noor was the first woman to operate, scale and IPO a company in the MENA region, listing Depa on NASDAQ Dubai and the London Stock Exchange for US$1.1 billion in April 2008. One of the world’s largest interior contractors, Noor scaled Depa tenfold, expanding operations from six countries to 22, including four cross-border acquisitions.

Identified by Forbes as one of the “World’s Top 50 Women in Tech” and by Arabian Business as one of the “Most Influential Arabs”, Noor's previous roles include Chief Investment Officer at The Dubai Future Foundation and a Founding Partner at Leap Ventures. Noor also founded the largest chain of yoga and pilates studios in the Middle East, ZenYoga, which was acquired by Cedarbridge in 2014.

Noor is an active, independent board director of Clue, the largest femtech company in Europe, and VAM Acquisitions Corp., a US based special purpose acquisition vehicle focused on the space ecosystem. She is the Founding Chairwoman of the Middle East Venture Capital Association, a Director of the Global Private Capital Association, TechWadi, and the Karman Fellowship.

She is a member of the Aspen Global Leadership Network and a member of the World Economic Forum’s Young Global Leaders. She previously held Board Director roles at MIT Sloan and was a founding board member of Endeavor UAE.

Noor holds Bachelors’ degrees in Finance and Economics from Boston College, an MBA from MIT Sloan.

Doris Taylor is a dynamic innovator, scientist, entrepreneur, and a global thought leader in regenerative medicine and biomanufacturing. She is passionate about creating cures for heart disease, which kills more people worldwide than any other disease and has an estimated economic impact of 219 billion dollars annually. In 2021she founded a new biotech company, Organamet Bio Inc. whose mission is to cure heart disease and reduce healthcare costs. Her first goal is to bioengineer personalized replacement hearts on demand. She is equally committed to making those therapies available fairly, equitably, and as soon as they are shown to be safe and effective.

Taylor is credited with the first functional scientific repair of injured heart with stem cells in 1998. Her group further transformed the field of organ transplantation science in 2008 by developing a unique cell removal (decellularization) method that makes un-transplantable organs into usable scaffold frameworks for building new organs with stem cells. This was so revolutionary it was recognized as one of the “Top 10 Research Advances” by the American Heart Association and Taylor was nominated as one of “100 most influential people in the world” by Time magazine. Next, she turned to disease prevention and has begun to develop “cellular signatures” of heart disease and aging that appear to differ by sex, race and ethnicity.

Dr. Taylor frequently appears as an expert on cell therapy, women’s health, cardiac repair and organ transplantation in the public media. Her work has been recognized and featured by 60 Minutes, CNN, The New York Times, The Wall Street Journal, Forbes, National Geographic, BBC Horizon, BBC News Health, ABC, NBC and CBS News, Associated Press, Good Morning America, NOVA Science Now, PBS NOVA Transplanting Hope, Discovery Channel’s Through the Worm Hole with Morgan Freeman, Science Channel’s Stem Cell Universe with Stephen Hawking, NPR’s On Being with Krista Tippet, Sanjay Gupta’s Champions for Change and most other worldwide media outlets.

Her motto is, “Build the Future Today – and Do It With Heart.”

Mr. Rasesh “Sesh” Thakkar serves as Senior Managing Director of Tavistock Group and has been with the Group for 25+ years. Mr. Thakkar’s areas of experience ranges across industries such as life sciences, financial services, real estate, and leisure services as well as corporate finance and structures, mergers and acquisitions, strategic planning and operations. He’s also known for being one of the main visionaries behind Lake Nona.

Currently, he serves on the Board and Governors Council of the Orlando Economic Partnership. He is also on the Board of Directors of GuideWell Mutual Holding Corporation and TECO Energy and is a member of the Board of Trustees of the Tavistock Foundation and the Florida Governor’s Council of 100.

Glen Tullman is the Chief Executive Officer of Transcarent, the first comprehensive, consumer-directed health and care platform that makes it easy for people to access high-quality, affordable health and care. Transcarent is transforming healthcare with WayFinding, an experience powered by clinicians and generative AI where Members can “Just Ask Transcarent” to instantly get trusted health and benefits navigation, take the next step with personalized clinical guidance, and access on-demand care delivery.

Tullman is the former Executive Chairman, Chief Executive Officer, and Founder of Livongo Health, the first at-scale consumer digital health company to truly empower people with chronic conditions to live better and healthier lives using data science. In his final year, Glen led Livongo through the largest consumer digital health Initial Public Offering in history, a secondary offering, a convertible debt offering that raised over $550 million, and the industry’s largest merger to date between Livongo and Teladoc Health, valuing Livongo at $18.5 billion and beginning a new era of consumer-directed virtual care.?

A visionary leader and entrepreneur, Tullman previously ran two other public companies that changed the way health care is delivered. During his time as Chief Executive Officer of Allscripts, the Company was the leading provider of electronic prescribing, practice management, and electronic health records for physician practices. Glen led Allscripts IPO and Secondary offerings. Prior to Allscripts, he was Chief Executive Officer of Enterprise Systems, the leading resource management systems for hospitals, which he also took public and then sold to McKesson/HBOC. Before entering healthcare, Glen served as President and COO of CCC Information Systems, a provider of computerized systems for the property and casualty insurance sector.?

Glen is also one of two Founding Partners at 7wire Ventures, one of the highest-returning venture capital funds in Illinois. He is the author of On Our Terms: Empowering the New Health Consumer, in which he proposes new solutions to address the chronic condition epidemic facing our country.?

A strong proponent of philanthropy, Glen was honored in 2019 with a Robert F. Kennedy Human Rights Ripple of Hope Award for his career focused on improving the safety, empathy, and efficiency of our healthcare system. He also serves as a Life Director of the Illinois Chapter of Breakthrough T1D, the leading organization advancing life-changing breakthroughs for Type 1 Diabetes.?

Glen has three amazing children and four grandchildren who inspire him every day.

Brian S. Tyler, Ph.D. is chief executive officer of McKesson Corporation. With more than two decades of experience across McKesson, Brian has led nearly every major business within the company.

Brian earned a Ph.D. and master’s degree from the University of Chicago and a B.A. in Economics from the University of California

Anna oversees KPMG’s network of 5,000 professionals who provide Audit, Tax and Advisory services to healthcare organizations in more than 70 countries. She has advised providers, payors and government bodies on a range of areas, including care system redesign, payment reform, tech-enabled transformation, and healthcare strategy. Anna sits on the Steering Committee of the Partnership for Health System Sustainability and Resilience, a collaboration between the World Economic Forum, London School of Economics, KPMG, the WHO, Philips and AstraZeneca. Prior to KPMG, Anna held senior-level positions in a range of healthcare institutions, and headed the Dutch Diagnosis Related-Group office’s major payment reform efforts.

Lindsey Vonn is a recently retired Olympic gold and bronze medal?winning alpine ski racer for the U.S. Ski Team as well as a New York Times bestselling author. She is the most successful female skier of all time and holds four World Cup titles, making her one of only 6 women to win World Cup races in all five disciplines of Alpine skiing.

Debuting first at the 2021 Alpine Skiing World Cup Races, Vonn is an NBC Sports broadcast analyst. Lindsey served as an International Games Ambassador in the 2018 Winter Olympics. Lindsey is also the founder of the Lindsey Vonn Foundation, established to empower young girls. She splits her time between Park City, Utah and Los Angeles, California.

Mark Walker joined ESPN in 2019, as Head of Sports Business Development and Innovation, where he leads ESPN’s business development center of excellence, with particular focus on driving sports media innovation in business, products and experiences.

In his role, Walker is responsible for driving ESPN Edge – a collaboration with other technology leaders to enable new ways for fans to experience sports – continuing to lead ESPN’s strategic efforts in the sports betting space, and expanding The Undefeated content vertical across The Walt Disney Company (TWDC).

Walker joined from the Disney Parks, Experiences and Products franchise group. In that role, he led global segment-wide initiatives aimed at building lifelong relationships between fans and key content franchises from Disney, Marvel, Lucas and Fox. Walker brings a wealth of experience to the innovation and business development disciplines, having led all of product development, marketing, programming, content, and operations for Disney’s network of digital gateways, social media presence and content-delivery apps.?He helped transform that collection of Disney marketing platforms into the coherent, multi-platform digital content engine now known as the Disney Digital Network.

Before joining TWDC in 2011, Walker was the head of the Yahoo! News and Information verticals, leading business development teams in the sports, entertainment, and lifestyle spaces. He also held business and legal affairs positions for several entertainment media companies in music, film, and television.
Walker earned a J.D. degree from Stanford Law School, an M.S. in Mechanical Engineering from Stanford, and a B.S. in Mechanical Engineering from MIT. He serves as an active member of the Media Arts and Sciences Visiting Committee for the MIT Media Laboratory. He is based out of ESPN’s New York office and reports to Jimmy Pitaro, Chairman, ESPN and Sports Content.

Andrew Weil, M.D., is a world-renowned leader and pioneer in the field of integrative medicine. Combining a Harvard education and a lifetime of practicing natural and preventive medicine, he is the founder and director of the Andrew Weil Center for Integrative Medicine at the University of Arizona, where he is a clinical professor of medicine and professor of public health. A New York Times best-selling author, Dr. Weil is the author of 15 books on health and wellbeing, including Mind Over Meds: Know When Drugs Are Necessary, When Alternatives Are Better, and When to Let Your Body Heal on Its Own; Fast Food, Good Food; True Food: Seasonal, Sustainable, Simple, Pure; Spontaneous Happiness; Healthy Aging; and Eight Weeks to Optimum Health. He is the editorial director of DrWeil.com, the leading online resource for healthy living based on the philosophy of integrative medicine. He is also a founder and partner in the growing family of True Food Kitchen restaurants.

Sherrie Westin is President of Sesame Workshop, the nonprofit educational organization behind Sesame Street. Westin leads the organization’s efforts to serve vulnerable children through mass media and targeted initiatives in the United States and around the world. She serves as Sesame Workshop’s chief mission ambassador, raising awareness, developing strategic partnerships, and cultivating philanthropic support to further the Workshop’s mission to help children everywhere grow smarter, stronger, and kinder.

Chris Wigley is the CEO of Genomics England, which exists to bring the benefits of genomic medicine to everyone. As the national steward of 60+ petabytes of human genome data from 100,000 volunteers, and a unique partnership with the NHS, Genomics England’s goal is to improve patient outcomes while lowering the cost of healthcare provision and advancing the innovation agenda in the UK. Through the COVID crisis, Chris was seconded as Senior Responsible Officer for Data to NHSX, and Genomics England launched a major research programme into the genomic drivers of severity of response to COVID.

Chris was previously COO at QuantumBlack, a bespoke Machine Learning company, and a Partner at McKinsey working on technology strategy topics. He has been a trustee of the New Entrepreneurs Foundation, and was on the Advisory Board of deep-tech VC Entrepreneur First as it scaled up. He previously worked for the?UK Foreign Office, establishing and leading?analytical work at the Counter Terrorism Policy Department to counter?chemical,?biological and nuclear?terror threats. Chris lives in London with his wife Tara and their three children.

A mother, an actress, an activist, a speaker, and a meditation teacher with a long-standing humanitarian engagement. A co-founder of the Never Alone, suicide prevention and mental wellbeing initiative of The Chopra Foundation. A movement that reduces mental health stigma and democratizes access to mental health hygiene tools. A Global Goodwill Ambassador to Skypower and the Honorary President of a grassroots charity in Myanmar. Wright lent her voice to UN Women and the UN Trust Fund to End Violence against Women.

Wright is the innovator of the Mental Hygiene Toolkit, a collection of mind cleansing and self-awareness tools to help individuals nurture their bodies, minds, and spirits, and develop inner guidance to consciously choose the best path for their lives. She has been a long-life student of Tibetan Buddhism and Vedanta.

Wright's acting and humanitarian projects bring her closer to understanding human nature and what binds consciousness to reality. She is the founder of the production company Conscious Intent, which supports different media formats to promote the human story. Her recent projects include "I Am Never Alone," which is the impetus for the Never Alone campaign with Dr. Deepak Chopra, Michael Beckwith, Temple Hayes directed by Michel Pascal.

As a motivational speaker, Wright has participated in numerous events, talk shows, podcasts, and social media outlets. Her recent engagements include UN Women conventions in London and Los Angeles, the First UN Trust Fund Grantee Convention in Bosnia and Herzegovina, the Difficult Dialogues forum in India, a suicide prevention seminar, and the Lake Nona Impact Forum. She is the annual host and co-founder of the Never Alone Summit, which features over 100+ speakers who share their strength and resilience tools in the mental health space.

Rachel Yehuda, PhD, is an Endowed Professor of Psychiatry and Neuroscience of Trauma. She is also Director of Mental Health at the James J. Peters Veterans Affairs Medical Center. Dr. Yehuda is a recognized leader in the field of traumatic stress studies, PTSD, and intergenerational trauma. In 2019, Dr. Yehuda was elected to the National Academy of Medicine for her seminal contributions to understanding the psychological and biological impact of traumatic stress. In 2020, Dr. Yehuda established and now directs the Center for Psychedelic Psychotherapy and Trauma Research.

Anna Stromer is a violist based in New England. As either a performer, session musician, or composer, she has worked with artists such as: Eminem, Michael Buble, Jacob Collier, 2Cellos, Itzhak Perlman, Josh Groban, Cyndi Lauper, Jared Leto, and Wyclef; and cultural institutions including Boston Ballet, Kansas City Ballet, and MTV Unplugged. Her string quartets have performed for President Barack Obama and Conan O’Brien and have been featured on Good Morning America as well as TV shows such as Modern Family and Gossip Girl.

Nathaniel Taylor, an Filipino/African-American/Cherokee cellist, is establishing himself as a passionate and charismatic performer with a variety of Classical, Jazz, Pop, and RnB engagements. In October 2020, Nathaniel collaborated with cellist Yo-Yo Ma on the IDAGIO network, performing a duet of the spiritual “Nobody Knows the Trouble I’ve Seen”. In December 2021, he joined the roster of Palaver Strings, a conductor-less string ensemble based in Portland, Maine. Nathaniel is also the current guest cellist for Sons of Serendip, a classical crossover quartet that won 4th prize at America's Got Talent. Nathaniel is an advocate for diversity and representation, and frequently works with/mentors the next generation to reach their potential. Nathaniel received an Artist Diploma from the Boston Conservatory at Berklee, where he studied with Rhonda Rider and Patrice Jackson.

Claudius Agrippa is a 22 year old award winning violinist and composer from Brooklyn, New York. Starting off in a classical studio at Juilliard, Claudius ended up studying jazz and modern music at Berklee College of Music. He has performed and toured with musicians such as Peter Yarrow, Sammy Rae and Roger Waters. Claudius was also the recipient of the debut prize for the New York Concerti Sinfonietta. As an avid improviser, arranger and collaborator, Claudius continues to break the mold of what it means to be a professional violinist.

Known for her vibrant performance style and engaging musicality, Gioia Gedicks is a classically trained violinist with a myriad of experiences and interests, encompassing multiple genres and ensembles. Recent awards include first prize in the Lynn Conservatory Chamber Competition as first violinist of the Kourdisma string quartet, second prize in the Mary Hilem Taylor Music Scholarship Competition in association with Palm Beach Symphony, 2022 scholarship recipient from the National Society of Arts and Letters, and the Lynn Conservatory Concerto Competition. Gedicks has performed alongside the genre-defying band Time for Three, was a fellow of the Adirondack Performing Arts Fellowship, and has performed and coached as an Artist in Residence for pianoSonoma directed by Michael and Jessica Shinn. Additionally, she is a featured soloist on a Cannes International Film Festival Official Selection. Gedicks received her Bachelor of Music from Boston Conservatory at Berklee studying with Katie Lansdale, and is currently pursuing her Master of Music degree at Lynn Conservatory with Guillermo Figueroa.